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ABSTRACT 
 
 
 
Previous studies demonstrated that retinol administration to ewes, followed by 
natural service, resulted in embryos with improved competence to develop in vitro.  In 
vivo studies with sheep and in vitro experiments with bovine embryos, were designed to 
evaluate the effects of retinol and to understand its mechanism(s) of action.  
The primary objective of the first experiment was to analyze ovine oocyte 
metabolism, and to assess the effects of retinol on this process.  Sheep oocytes were 
matured in vitro over a 24 hour period in the presence of different radiolabeled substrates.  
Results revealed that oxidative metabolism measured by glutamine showed no significant 
differences over all time periods.  Pyruvate oxidation was highest early in maturation and 
then decreased.  Glycolysis was highest at the middle time period.  Differences in 
metabolism between oocytes from retinol-treated ewes and those from control ewes were 
not detected. 
Next, varying concentrations of retinol were added either during in vitro 
maturation (IVM) or in vitro culture (IVC) of bovine oocyte and embryos, respectively.  
Our results demonstrated that 5µM retinol supplementation during IVM tended to 
improve embryonic development measured by the rate of blastocyst development.  This 
concentration proved even more beneficial if the control blastocyst rate was below 20%.  
Furthermore, 10µM retinol appeared detrimental during IVC but not during IVM.   
In the third experiment, we evaluated the effects of 5µM retinol and 100µM 
cysteamine on bovine oocyte glutathione content.  In addition, we investigated the 
combinatorial effects of retinol and cysteamine on in vitro bovine embryonic 
 vi
development.  We did not observe an increase in glutathione levels in bovine oocytes 
treated with retinol.  However, in the presence of cysteamine bovine oocytes exhibited an 
increase in glutathione content.  Retinol and cysteamine treatment during IVM and IVC 
increased bovine blastocyst development, which may indicate that retinol is increasing 
the utilization or uptake of cysteine from the medium. 
Next, we evaluated the role of exogenous retinol supplementation to 
superovulated ewes on the glutathione content of mature oocytes collected from the 
oviducts.  Our results did not reveal differences in glutathione content of oocytes from 
retinol-treated ewes versus those from control ewes.  Antioxidant transcripts encoding for 
Mn-SOD, Cu-Zn SOD, GS, and GSTp, were detected in ovine oocytes matured in vivo. 
However, retinol did not appear to impact the expression levels of these transcripts. 
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CHAPTER 1 
 
Introduction and Literature Review 
 
INTRODUCTION 
 
 
Retinoids are a group of small organic molecules that play important biological 
roles in many physiological processes including morphogenesis, cellular growth, and 
differentiation (Gudas et al., 1994; Sporn and Roberts, 1994).  The most common 
retinoids are: all–trans retinol, all-trans, 9-cis- and 13-cis-retinoic acid, and retinal.  The 
two main dietary sources of vitamin A (retinol) include β-carotene found in plants and 
retinyl esters found in animal products.  Intestinal enzymes convert the β-carotene and 
retinyl esters to retinal and retinol, respectively.  Retinol interacts with long-chain fatty 
acids to form retinyl esters that are packaged into chylomicrons and stored in the liver.  
Retinol is complexed to retinol binding protein (RBP) in the liver (Blomhoff et al., 1990; 
Gudas et al., 1994; Wolf, 1996).  RBP and intracellular retinoid binding proteins help 
regulate vitamin A homeostasis by sequestering and stabilizing retinol; thereby, allowing 
only certain enzymes access to the molecule (Mangelsdorf et al., 1994; Ghyselinck et al., 
1999;  review Noy, 2000).  Several alcohol or retinol dehydrogenases catalyze the 
conversion of retinol to retinal.  Next, retinal can be converted to retinoic acid by retinal 
dehydrogenases (Ong et al., 1994; Napoli, 1999;  review Noy, 2000).  Retinoic acid is 
considered the most biologically active, natural retinoid, and it impacts transcription of a 
number of genes by binding to and activating two different types of nuclear retinoic acid 
receptors (Figure 1-1).   
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Figure 1-1.  Diagram of retinoid metabolism and the mechanism of action of retinoic 
acid. 
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Due to an increase in the manipulation of preimplantation embryos both in 
agricultural and human-related fields, it is of great interest to determine the factors that 
influence an embryo’s viability and developmental competence.  Previous studies from 
our lab and others (Besenfelder et al., 1996; Da Silveira et al., 1998; Eberhardt et al., 
1999b; Chew et al., 2001; Livingston et al., 2002) concluded that vitamin A plays a vital 
role in the reproductive cycles of many different animal species, as well as influencing 
proper embryo development.  Thus, it was the goal of this study to help elucidate the 
mechanisms of action of retinol on oocyte and early embryonic development.  
Specifically, the objectives were: 
1.) To analyze the metabolism of sheep oocytes throughout their maturation     
period and to determine if retinol affects this process.  
2.) To assess the in vitro effects of retinol on bovine embryo development. 
3.) To identify mechanisms by which retinol is positively impacting oocyte 
maturation and early embryonic development. 
 
 
LITERATURE REVIEW 
Vitamin A and Reproduction 
The importance of vitamin A in many biological processes has been well 
characterized since the late 1800’s, but observations on the requirement for vitamin A can 
be traced to early Egyptian times (1500 B.C) in which historians have found references to 
night blindness being treated with “ox liver” (review Napoli, 1996).  In 1907 E.V. 
McCollum began his research studying the chemical composition of animal feed.  He 
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observed that cows fed a vitamin A deficient diet became blind and gave birth to dead 
calves (McCollum, 1964).  Later, in 1957, Moore reported that vitamin A deficiency led 
to faulty dark adaptation, decreased growth and weight during development and mucous 
membrane injuries.   
Vitamin A deficiencies have been linked to a variety of reproductive disorders in 
different species such as decreased size of ovaries and testes in farm animals (Ganguly, 
1989).  In birds, embryos from hens deprived of retinol die after 48 hours of incubation 
(Thompson et al., 1969).  A recent study in rats demonstrated an association between 
vitamin A deficient diets during pregnancy and abnormal placental apoptosis (Antipatis 
et al., 2002).  Vitamin A deficiency also led to the discovery that vitamin A plays an 
important role in the biosynthesis of steroid hormones (Juneja et al., 1966), and 
cholesterol side-chain cleavage enzyme activity in the ovaries and testes of rats (Jayaram 
et al., 1973).   
Several studies have concluded that vitamin A supplementation of animal diets 
increases reproductive success.  For example, prevention of fetal resorption occurred if 
retinol was administered to vitamin A-deficient rats prior to Day 10 of gestation (Wellik 
and DeLuca, 1995).  Rabbits treated with β-carotene during superovulation, showed an 
increase in the number of live births compared to controls (Besenfelder et al., 1993).  In 
sows fed diets supplemented with adequate vitamin A, litter size in gilts was increased by 
injection of either β-carotene or vitamin A (Coffey and Britt, 1993).   
Injections of vitamin A prior to ovulation increased the number of embryos from 
gilts fed high-energy diets (Whaley et al., 1997).  In addition, retinol injections to gilts 
fed a high-energy diet increased the follicular fluid concentration of progesterone and 
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insulin-like growth factor (IGF-1) (Whaley et al., 2000).  In cattle, retinol injection in 
combination with FSH-induced superovulation has been reported to improve embryo 
quality, determined by visual assessment (Shaw et al., 1995), and improve cattle oocyte 
recovery by ovum pick-up (OPU) (Hidalgo et al., 2002).  Increased ovulation rates and 
increased recovery of embryos were also observed in retinol-treated superovulated mice 
(Elmarimi et al., 1990). 
Retinoic acid (RA), the most bioactive metabolite of retinol is essential for normal 
embryonic and fetal development (Marshall et al., 1996; Ward and Morriss-Kay, 1997; 
Maden, 2000).  One study reports that certain concentrations of retinoic acid influences 
the ability of follicle stimulating hormone (FSH) to induce luteinizing hormone receptors 
in rat granulosa cells (Bagavandoss and Midgley, 1988), and later studies by Minegishi 
and co-workers observed a RA-induced increase in FSH receptors (Minegishi et al., 
2000).  Although excessive amounts of retinoic acid provided to embryos in vitro is 
detrimental or even fatal (Ward and Morriss-Kay, 1997; Huang et al., 2001; Huang et al., 
2003), recent evidence suggests that 9-cis-retinoic acid may improve early embryonic 
development and quality if provided to meiotically inhibited bovine oocytes (Duque et 
al., 2002).  Furthermore, a cumulative effect of retinol treatment to heifers and in vitro 
retinoic acid treatment of embryos tended to increase blastocyst development (Hidalgo et 
al., 2002). 
Based on previous data collected in our lab, morula stage embryos collected from 
sheep treated with all-trans-retinol prior to ovulation, and then cultured in vitro had a 
higher blastocyst rate (72%) compared to embryos from control sheep (32%).  In a 
similar experiment the oviducts of ewes were flushed, 1-4 cell stage embryos were 
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collected and cultured in vitro.  Again, blastocyst development was significantly higher in 
retinol treated ewes (70%) compared to control (5%).  Another intriguing observation 
was that most embryos from control but not retinol treated ewes, blocked at the eight-cell 
stage in vitro (Eberhardt et al., 1999b).  These data suggest that retinol may assist zygotic 
gene activation in both sheep and cattle.  Without proper signals a sheep or cow embryo 
will block at the 8-16 cell stage in vitro, which is when the maternal genome is turned off 
and the embryonic genome is activated (Telford et al., 1990).  Expanding on these results, 
further experiments were conducted in vitro to assess whether similar conclusions could 
be made about the beneficial effects of retinol. 
Oocytes collected from abbatoir cattle ovaries were matured, fertilized, and 
cultured in vitro.  Addition of 5µM retinol to the culture medium significantly improved 
embryo development to the blastocyst stage compared to controls (29% vs. 12%).  These 
particular experiments were performed in a 20% oxygen atmosphere (Livingston et al., 
2002).  Later studies showed similar results with 5µM retinol addition to the oocyte 
maturation medium, and subsequent development to the blastocyst stage.  This 
experiment was performed in a low oxygen atmosphere (7%).  Interestingly, if the control 
blastocyst rate was below 20%, possibly an indication of embryonic stress, the effect of 
retinol treatment was most dramatic (Livingston et al., 2002). 
 
Vitamin A Chemistry   
Retinoids are a group of small, lipophilic molecules that play an essential role in 
many physiological processes such as vision, skin, bone, and nervous system 
development, epithelial differentiation, reproduction, and immune system function 
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(review Napoli, 1999).  According to Sporn and Roberts (1994), retinoids are “substances 
that can elicit specific biologic responses by binding to and activating a specific receptor 
or set of receptors, with the program for the biologic response of the target cell residing 
in the retinoid receptor rather than in the retinoid ligand itself.”  Common, naturally 
occurring, retinoids include vitamin A or retinol (ROH), retinal and retinoic acid (RA).  
Retinal is one of several unique retinoids required in visual tissues (Saari, 1994).  The 
two most abundant forms of RA include all-trans-retinoic acid and 9-cis-retinoic acid.   
The most common provitamin A molecules, and the two major dietary sources of 
retinoids are retinyl esters, primarily found in animal fat, and β-carotene found in plants.  
Retinyl esters are converted to retinol in the intestinal lumen, and β-carotene is cleaved 
by the intestinal enzyme β-carotene dioxygenase (BCDO) to form two molecules of 
retinal (Ross et al., 2001).  The intestinal enzymes acyl coenzyme A:retinol 
acyltransferase (ARAT) and lecithin:retinol acyltransferase (LRAT) convert retinol into 
retinyl esters, which are packaged into chylomicrons.  The retinyl esters (the main form is 
palmitate) can be stored in the liver, the primary storage site of retinoids.  LRAT 
preferentially acts on retinol when complexed to cellular retinoid binding protein 
(CRBP), while ARAT mainly esterfies uncomplexed retinol (Blomhoff et al., 1990).  
These enzymes as well as retinoid binding proteins help maintain a delicate balance of 
free versus stored retinol (Blaner and Olson, 1994; Ong et al., 1994). 
 
Retinoid-Binding Proteins 
In parenchymal cells of the liver, retinol is complexed to a retinol binding protein 
(RBP), a 21,000 Da plasma protein, belonging to a class of proteins called lipocalins.  Its 
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structure has been well characterized as well as its interactions with retinol, specifically 
all-trans-retinol ( review Newcomer and Ong, 2000; review Noy, 2000).  Before RBP-
ROH is transported out of the liver it first interacts with an accessory protein called 
transthyretin (TTR) (Wolf, 1995).  This association is thought to protect the complex 
from renal filtration (review Noy, 2000).  Once the complex reaches its target tissue, TTR 
dissociates.  Exactly how retinol is internalized is still a matter of debate and the 
mechanism is most likely different for various cell types.  In the aqueous environment of 
the cytosol retinol is bound to specific carrier proteins termed cellular retinol-binding 
proteins (CRBPs) (Ong et al., 1994). 
Studies exist supporting receptor-mediated uptake of retinol from RBP as well as 
those supporting receptor-independent uptake of retinol from RBP (review Soprano and 
Blaner, 1994).  Using an affinity-tagged recombinant CRBP assay, Sundaram and 
colleagues provided evidence of a membrane receptor in placental membranes (Sundaram 
et al., 1998).  They demonstrated that the transfer of [3H] retinol from RBP to CRBP was 
greater in the presence of membranes than in their absence.  Furthermore, they suggested 
that it was a protein receptor because the transfer was greatly inhibited in the presence of 
protein denaturation agents.  Tosetti and co-workers showed evidence of RBP 
endocytosis but failed to show direct proof of a RBP membrane receptor (Tosetti et al., 
1999).  In the yolk sac of cultured rat embryos, evidence exists for receptor-mediated 
RBP uptake, which may explain how embryos acquire and utilize maternal retinol (Ward 
et al., 1997).  On the other hand, in cultured rat Sertoli cells the RBP-retinol complex is 
recognized at the cell surface, but only retinol is internalized (Shingleton et al., 1989).  A 
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recent study using renal proximal tubal cells discovered that an endocytic receptor called 
megalin, is responsible for RBP transport in these kidney cells (Marinó et al., 2001).   
Noy and colleagues provided evidence that retinol can rapidly dissociate from its 
binding sites on RBP, and they suggested that free retinol might enter the cell by 
partitioning in the plasma membrane (Noy and Xu, 1990).  Another study using liver 
cells and a marker for receptor-mediated endocytosis, concluded that RBP is taken up by 
potocytosis, an endocytic pathway that utilizes caveolae instead of clathrin-coated pits 
(Malaba et al., 1995). 
After retinoids enter the cell, carrier proteins bind and help stabilize these 
hydrophobic molecules.  Retinoids have a detergent-like structure which would be 
deleterious to cellular and organelle membranes; therefore, since carrier proteins have a 
high binding affinity, they help regulate the pool of soluble, diffusible retinoid-protein 
complexes (Ong et al., 1994).  In addition, these proteins modulate the metabolism of 
retinoids, allowing some enzymes access and restricting access of others (Ong et al., 
1994; Sundaram et al., 1998).   
Cellular retinoid binding protein I and II (CRBP I, II) are 56% identical, they are 
highly conserved (91%-96% sequence identity) among human, rat, mouse, pig, and chick, 
and they both interact with all-trans-retinol and all-trans-retinal (review Noy, 2000).  
CRBP I is expressed in multiple fetal and adult tissues, including reproductive organs.  
CRBP II is expressed in the adult small intestine and in some fetal tissues (review Noy, 
2000). 
The two primary functions of CRBP I are vitamin A storage and retinoic acid 
synthesis.  In vitamin A sufficient animals, CRBP is saturated with retinol and LRAT can 
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act on the CRBP I-retinol complex to convert retinol to retinyl esters.  In contrast, during 
a deficient state apo-CRBP I will stimulate the liberation of stored retinol from retinyl 
esters (review Ong et al., 1994; Noy, 2000).  CRBP I allows only certain enzymes access 
to retinol.  Since CRBP II is only expressed in the adult small intestine it plays a role in 
processing vitamin A from food.  This protein sequesters retinol, restricting its access to 
only a few microsomal enzymes.  CRBP II also participates in controlling the rate of 
esterification of retinol in the enterocytes (review Noy, 2000). 
Depending on the cell type, one of three isoenzyme families have the potential to 
oxidize retinol to retinal, the rate-limiting step in retinoic acid synthesis.  These include 
the alcohol dehydrogenases (ADH), retinol dehydrogenases (RoDH), and members of the 
P450 superfamily (Ross et al., 2001).   Actually, P450 enzymes are responsible for 
metabolizing retinoic acid into more oxidized forms; thus, controlling its intracellular 
levels and excretion (Fujii et al., 1997).  A double null mouse mutant for the genes Adh1 
and Adh2 was created, and results demonstrated that they have non-overlapping roles.  
Specifically, ADH1 is responsible for minimizing vitamin A toxicity, and ADH4 is 
essential during a vitamin A deficient state (Deltour et al., 1999).  Recently, ADH3 was 
determined to be a cytosolic retinol dehydrogenase, which also contributes to RA 
synthesis (Molotkov et al., 2002). 
Retinal can be converted to retinoic acid by the aldehyde dehydrogenases 
(ALDH).  In humans, the retinal dehydrogenase (RaDH) is known as ALDH1 (Ong et al., 
1994;  review Napoli, 1999; Elizondo et al., 2000;  review Noy, 2000).  The importance 
of this enzyme was observed in homozygous knockout mutant mice where the embryos 
died at midgestation (Neiderreither et al., 1999).   
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The other important intracellular retinoid proteins are cellular retinoic acid 
binding protein I and II (CRABP I, II), which primarily bind all-trans-retinoic acid.    
They display a high sequence similarity and are highly conserved across species.  Their 
distribution across tissues is cell type and developmental stage dependent.  For example, 
CRABP I in the adult is expressed almost everywhere, but CRABP II is only expressed in 
the skin, uterus, ovary, and choroid plexus (review Ong et al., 1994; Bucco et al., 1995; 
Noy, 2000).  In the embryo both are present but in different tissues.   
The function of these two binding proteins is still not clearly understood.  Like the 
other retinoid binding proteins they serve to modulate the activities of enzymes that 
influence the synthesis and availability of retinoic acid.  In addition, studies propose that 
they deliver their ligand to the nucleus where RA can gain access to the nuclear retinoic 
acid receptors.  Noy has proposed two different mechanisms by which this transfer could 
occur:  indirect association between the CRABP and the target receptor or a direct 
“channeling” process requiring contact between the CRABP and the target receptor (Noy, 
2000).  In a recent study, Budhu and Noy (Budhu and Noy, 2002) demonstrated that 
CRABP-II is translocated to the nucleus upon binding to RA, and it modulates retinoic 
acid receptor mediated biological activities of RA. 
The importance of retinoid-binding proteins is observed in knockout (KO) mouse 
models and in human disease states.  For example, low circulating levels of RBP can lead 
to night blindness even in the presence of sufficient vitamin A (review Ross et al., 2001).  
CRBP I KO mice are healthy and fertile, but their retinyl ester storage supply decreases 
by 50%.  If these animals are fed a vitamin A-deficient diet they experience vitamin A 
deficiency syndrome (VAD) and their growth is greatly retarded; therefore, it was 
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suggested that CRBP I may not be necessary for RA synthesis but it is required for proper 
retinoid homeostasis (Ghyselinck et al., 1999).  In contrast, a null mutation of the 
CRABP I gene in mice resulted in embryos that were apparently normal, leading to the 
conclusion that this mutation did not interfere with normal growth, development, and 
differentiation (de Bruijn et al., 1994).  If dietary vitamin A is limited during pregnancy, 
then offspring of CRBP II knockout mice die within 24 hours after birth (XP et al., 2002). 
 
Retinoic Acid Receptors 
Retinoic acid impacts transcription through two nuclear receptor families which 
are members of the steroid/thyroid hormone receptor superfamily:  retinoic acid receptors 
(RARs) and retinoic acid X receptors (RXRs).  RARs consist of three subtypes (RARα, 
RARβ, RARγ), which are activated by all-trans-RA and 9-cis-RA.  The RXRs (RXRα, 
RXRβ, RXRγ) are highly activated by 9-cis-RA (Mangelsdorf et al., 1994).  These two 
receptors are surprisingly dissimilar.  In fact, RAR is more related to the thyroid hormone 
receptor than to RXR (Mangelsdorf et al., 1994). 
The RARs and RXRs can form homo- or heterodimers depending on the cell type.  
They bind to retinoic acid response elements (RAREs, RXREs), which flank the 
promoter regions of a number of RA-inducible genes (Mangelsdorf et al., 1994; Marshall 
et al., 1996; Rohwedel et al., 1999).  RAREs or RXREs consist of a minimal half-site 
consensus sequence (AGGTCA) configured into a variety of structured motifs 
(Mangelsdorf et al., 1994).  The RAR/RXR response elements are organized into direct 
repeats spaced 3, 4, or 5 nucleotides apart (Mangelsdorf and Evans, 1995).  RXRs can 
also form heterodimers with vitamin D, thyroid hormone receptors, and peroxisome 
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proliferator-activated receptor (PPAR), which can act as transcription factors or co-
activators of transcription factors.  The response elements for these heterodimer partners 
are organized as a direct repeat as well, but only spaced 1 or 2 nucleotides apart 
(Mangelsdorf and Evans, 1995). 
Once retinoic acid is produced it can directly or indirectly affect the phenotype of 
a cell.  RA binding to RARs or RAR/RXR and subsequent association with RAREs 
mediates direct action.  This process is thought to be very fast (few minutes to few hours) 
and does not require de novo protein synthesis (Gudas et al., 1994).  Indirect actions can 
vary depending on the cell type and its state of differentiation.  Examples include 
activation or repression of transcription factors, translation or post-translational 
processing, induction of protein synthesis, and even modification (retinoylation) of 
certain cellular proteins (Gudas et al., 1994).  Furthermore, many biological metabolites 
of retinol exist, like β-glucoronide, which may also mediate or mimic the effects of RA 
(Blaner and Olson, 1994).   
Several studies provide evidence that single mutant knockouts, of either RAR or 
RXR do not display apparent phenotypic abnormalities, suggesting a functional 
redundancy of these nuclear receptors (review Maden, 2000;  review Ross et al., 2000).  
For example, if the predominant isoform, RARα1, was knocked out in mice the resulting 
offspring were normal.  However, if the entire RARα gene was disrupted, early 
embryonic lethality occurred (Lufkin et al., 1993).  Interestingly, one study reported that 
these RARα mutant mice developed lymphoma within two months, and that the tumors 
displayed a down-regulation of the p53 and bcl-2 genes (Haidar et al., 2000).  RARβ 
mutants were phenotypically normal and fertile; however, if an RARα/RARβ double 
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mutant was created, the mice developed abnormally (Ghyselinck et al., 1997).  
Furthermore, double null mutant RXR α-/- and β-/- knockout mice failed to develop 
properly during embryogenesis (Wendling et al., 1999).  One laboratory utilized a 
retinoid receptor antagonist in the mouse to clarify the roles of retinoic acid receptors 
during embryogenesis, and they discovered that the antagonist effect was stage and dose 
dependent (Kochhar et al., 1998). 
 Extensive work demonstrates that retinoic acid plays an important role in cellular 
differentiation and embryo body patterning (review Hofmann and Eichele, 1994).  Some 
of the well-known genes that RA regulates or modulates include the homeobox or Hox 
genes, responsible for temporal and spatial body patterning (review Hofmann and 
Eichele, 1994), transforming growth factor-β, growth hormone, progesterone, enzymes 
such as alcohol dehydrogenase, transglutaminase, extracellular matrix proteins, and gap 
junctional proteins (Gudas et al., 1994). 
 
Localization of Retinoids and Their Associated Proteins in Reproductive Tissues 
 
Determining the actual retinoid content of embryos is difficult considering the 
amount of available tissue present in embryos.  Studies have attempted to analyze the 
retinoid content using HPLC methods (Bucco et al., 1995; Horton and Maden, 1995; 
Maden, 2000).  Results consistently show a graded, relatively non-specific distribution 
over the entire embryo, but localization of retinoid-associated proteins and their receptors 
has met with more success.  Indeed, since these proteins and receptors mediate the 
transport, cellular accumulation, metabolism and actions of retinoids, their expression in 
the reproductive tract has been an area of much investigation.   
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In presomitic rat embryos, a RBP receptor, CRBP, retinol dehydrogenase, and 
retinal dehydrogenase were localized in certain tissues (Båvik et al., 1997).  Recently, a 
study characterized the expression of the three subtypes of RXRs, alcohol dehydrogenase 
(ADH), retinaldehyde dehydrogenase II (RALDH2), and PPARγ in early preattachment 
bovine embryos (Mohan et al., 2002).  This same study demonstrated that RXRα and β 
isomers, RALDH2, and PPARγ were expressed in all stages of development from the 
oocyte to the hatched blastocyst.  These four transcripts were present in both the inner 
cell mass and the trophectoderm.  These results indicate that the early vertebrate embryo 
possesses the mechanisms to synthesize and utilize retinoic acid.  Furthermore, several 
studies confirmed the presence of retinoid binding proteins in the ovarian follicle, 
oviduct, uterus, and placenta; thus, confirming the machinery to mediate the actions of 
retinol and retinoic acid on the early embryo and developing fetus are present. 
Reports from our laboratory illustrated that RBP and CRBP-I was 
immunolocalized in the thecal cell layers of non-atretic antral follicles in the ovine ovary.  
Unlike CRBP-I or CRABP, RBP was found in the granulosa cells.  RBP was also 
localized in the cytoplasm of oocytes from antral follicles.  CRABP was 
immunolocalized to oocytes from primordial follicles only (Eberhardt, unpublished).  In 
the bovine ovary RBP was detected in theca and granulosa cells of antral and preantral 
follicles, CRBP was localized in the granulosa of antral follicles and in large luteal cells, 
and RBP was also expressed in large and small luteal cells (Brown et al., 2003).  
Subsequently, northern blot analysis confirmed mRNA expression of these retinoid-
binding proteins.  Zheng and co-workers provided evidence of CRABP II expression in 
rat granulosa cells and the uterine epithelium during estrous (Zheng et al., 1999).  Studies 
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in rats detected RBP receptors in embryonic tissues (Morris-Kay & Ward, 1999).  
CRABP II appeared only in the cytoplasm of luteal cells in the rat ovary corresponding to 
an increase in progesterone levels (Bucco et al., 1995).   
Analysis of bovine follicular fluid revealed the presence of retinol and RBP, and 
estradiol concentrations were positively correlated suggesting a healthier follicle (Brown 
et al., 2003).  These studies indicate the existence of transport mechanisms that deliver 
retinol from the plasma into the follicle and ultimately to the oocyte.  Once an oocyte is 
released from the follicle, it travels in the oviduct where fertilization occurs, and then 
continues to the uterus.  Consequently, evidence also exists for the localization of retinoid 
proteins in the oviduct and uterus during this time period. 
Expression of RBP by ovine oviducts was higher on Day 1 of the estrous cycle 
(Day 0 = estrus) than on Day 5 or Day 10.  Furthermore, its expression was upregulated 
when estrogen was added to the culture medium (Eberhardt et al., 1999a).  This suggests 
that retinol may be playing an important role during early embryo transport.  In fact one 
study provided evidence that the retinol-binding protein 4 (RBP4) gene is one possible 
marker for increased litter size in pigs (Rothschild et al., 2000). 
In cows, RBP was detected in uterine flushings from different days of the estrous 
cycle (Liu and Godkin, 1992), and RBP was detected in the ovine endometrium (Doré et 
al., 1994).  A study conducted in our laboratory demonstrated RBP synthesis in the 
bovine occurred in both the uterine luminal and glandular epithelium (Mackenzie et al., 
1997).  Furthermore, RBP and CRABP were localized in the glandular and surface 
epithelium of the endometrium during early gestation in pigs (Schweigert et al., 1999).   
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RBP is present in the placental membranes in both the cow and sheep which 
suggests a mechanism by which retinol can be internalized and delivered to the placental 
tissues as well as the fetus.  For example, RBP mRNA was observed in expanding bovine 
conceptuses (Day 13) as well as in several of the extraembryonic membranes (Gao et al., 
1991; Liu et al., 1993).  The ovine placental membrane epithelium was also found to 
secrete RBP (Liu et al., 1992).  In the rat, during early gestation, the majority of retinol 
was found in the placenta, but by mid-organogenesis the embryo was found to contain 
higher levels of retinol (Satre et al., 1992). 
 
Oocyte Maturation and Embryonic Development 
Oocyte and embryonic development in vivo and in vitro is strongly influenced by 
the quality of the follicular environment in which the oocyte grows and matures (Boni et 
al., 2002; Sutton et al., 2003).  Interactions of the oocyte and granulosa cells are 
intricately regulated, and they cannot develop in isolation from one another (Driancourt 
and Thuel, 1998).  The follicular fluid is composed of a variety of proteins, growth 
factors, cytokines, steroids, energy substrates, and many unknown substances that 
regulate oocyte development (Sutton et al., 2003).  In turn, the oocyte produces many 
different factors, which affect granulosa cell proliferation, differentiation, and even 
steroidogenesis, including:  factor in the germline alpha (Figα), c-kit, growth 
differentiation factor –9 (GDF-9), and bone morphogenetic protein (BMP-15) (Eppig, 
2001; Matzuk et al., 2002; Wu and Matzuk, 2002; Sutton et al., 2003).  Furthermore, 
communication with somatic cells influences proper development of the egg including 
transcriptional activity and chromatin remodeling (De La Fuente and Eppig, 2001).   
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Upon completion of oogenesis an oocyte is arrested in the dictyate stage of 
prophase I.  In vivo, the preovulatory surge of gonadotropins, via communication with the 
granulosa cells, causes resumption of meiosis and release of the oocyte from the follicle.  
However, physical release of the oocyte followed by in vitro culture may also trigger 
meiosis to resume (Eppig et al., 1996; Driancourt and Thuel, 1998; Duranthon and 
Renard, 2001).  Oocyte maturation involves two distinct yet equally important processes:  
nuclear and cytoplasmic maturation.  Nuclear maturation refers to the progression of 
meiosis from prophase I to metaphase II (Xu et al., 1986; Dominko and First, 1997).  
Meiotic resumption in oocytes is regulated by several key factors including, mitogen-
activated protein kinase (MAPK) cascade, and the cyclin B-cylin dependent protein 
kinase-2 (cdc2), sometimes referred to as maturation or mitogenic promoting factor 
(MPF) (Sirard et al., 1998; Abrieu et al., 2001).  The cyclin is the regulatory subunit, and 
the Cdc2 is the catalytic subunit.  Both of these are controlled by somewhat species-
specific phosphatases and kinases (Yamashita et al., 2000).   
Cytoplasmic maturation involves redistribution of mitochondria, alterations in 
ATP content (Stojkovic et al., 2001), structural changes such as cortical granule 
realignment (De Loos et al., 1992; Abbot and Ducibella, 2001), and other organelle 
rearrangments (De Loos et al., 1992).  The timing and assessment of meiotic and 
cytoplasmic maturation have been characterized in domestic animals, humans, and 
rodents (Sorensen and Wassarman, 1976; Xu et al., 1986; Dominko and First, 1997; 
Hunter, 2000; Combelles et al., 2002); however, this developmental process is still not 
completely understood.  Closely associated granulosa cells, called cumulus cells, 
immediately surround the oocyte and play an important role in maintaining oocyte arrest, 
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inducing meiotic resumption, and supporting cytoplasmic maturation (Tanghe et al., 
2002).  These specialized cells provide the growing oocyte with essential nutrients and 
energy substances necessary for continued development (Sutton et al., 2003).  In addition, 
proper cumulus expansion in most, but not all mammals, is important for proper 
fertilization (Yanagimachi, 1988).   
Both meiotic and cytoplasmic maturation can be altered by substrate 
concentrations, and studies conducted on oocyte and early embryo metabolism (Leese 
and Barton, 1984; Rieger and Loskutoff, 1994; Downs and Utecht, 1999; Spindler et al., 
2000) have led to the identification of important nutritional requirements as well as 
improved culture conditions.  More recently, certain metabolic events have been linked 
with better viability after transfer (Krisher and Bavister, 1999; Spindler et al., 2000) and 
cryopreservation (Gardner et al., 1996).  For example, it has been reported that mouse 
blastocysts with lower glycolytic rates are more viable after transfer (Lane and Gardner, 
1996), while others have concluded that higher glycolytic rates in oocytes are more 
indicative of developmental competence (Krisher and Bavister, 1999; Spindler et al., 
2000). 
A key aspect of oocyte growth in the tertiary follicle is the accumulation of 
maternal RNA and proteins necessary for continued development of the embryo.  Zygotic 
gene activation (ZGA) or the maternal to embryonic gene transition occurs at different 
time intervals, depending on the mammalian species, following fertilization (Telford et 
al., 1990; Memili and First, 2000; Latham and Schultz, 2001).  This critical event is 
characterized by the initiation of transcription by the embryonic genome.  Since the 
discovery of this genomic reprogramming many studies have described several genes that 
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are expressed during this time ( review Memili and First, 2000; review Latham and 
Schultz, 2001).   
Many studies have been designed to identify factors that influence an 
oocyte/embryo’s developmental competence (review Overström, 2000;  review Trounson 
et al., 2001) such as oocyte diameter (Sorensen and Wassarman, 1976), meiotic 
maturation (Damiani et al., 1996), ATP content of oocytes (VanBlerkom et al., 1995), 
follicle size (Pavlok et al., 1992), metabolic activity (Rieger and Guay, 1988; Gardner et 
al., 1996), and timing of development (McKiernan and Bavister, 1994).  Perhaps the most 
common measure of developmental competence is the ability of an oocyte to progress to 
the morula and blastocyst stages.  Both of these embryonic stages are characterized by 
morphological and functional changes necessary for continued embryonic development.  
Briefly, the morula stage embryo is a group of closely adherent cells or blastomeres, 
connected by tight junctions that allow communication among the cells (Sutherland and 
Calarco-Gillam, 1983; Crosier et al., 2000).  Blastocyst stage embryos are distinguished 
by formation of a fluid-filled cavity, and differentiation of the inner cell mass (embryo) 
and the trophectoderm (future extraembryonic membranes) (review Watson, 1992).  
These developmental stages may be indicative of subsequent development. 
Clearly, oocyte and embryonic development is a complex process that is not 
completely understood; however, with an increase of IVF produced animals, the 
requirements for successful in vitro maturation and culture of oocytes and embryos are 
becoming more apparent   Continued research on the requirements of early embryonic 
culture conditions will provide the necessary methods needed to improve IVF and other 
manipulative techniques. 
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Reactive Oxygen Species Production during Early Embryonic Development 
Convincing evidence is provided by many studies that in vivo embryo production 
is superior to in vitro embryo culture ( review Bavister, 1995; Kubota et al., 1998; Crosier 
et al., 2000; Khurana and Niemann, 2000;  review Duranthon and Renard, 2001; Rizos et 
al., 2002).  One reason for diminished developmental competence in vitro may be 
excessive production of reactive oxygen species (ROS).  ROS are generated during 
normal cellular processes such as the intermediate steps of oxygen reduction; thereby, 
resulting in production of the superoxide anion, hydrogen peroxide, and hydroxyl radicals 
(Gutteridge, 1995;  review Dröge, 2002). 
Endogenous sources of ROS during embryo development include oxidative 
phosphorylation, NADPH oxidase (produces superoxide anion and hydrogen peroxide), 
and xanthine oxidase (degrades purine nucleotides).  Exogenous sources that may result 
in production of ROS, particularly during in vitro culture, include high oxygen 
concentration, metallic cations, visible light, and sperm (Salas-Vidal et al., 1998; review 
Guérin et al., 2001;  review Dröge, 2002).   The deleterious effects of ROS on 
preimplantation embryos include protein, lipid, and nucleic acid damage, mitochondrial 
alterations, cell cycle block, ATP depletion, and excessive apoptosis (Salas-Vidal et al., 
1998; Guérin et al., 2001).  Increased oxygen radicals in mouse embryos cultured in vitro 
are implicated in developmental blockage that is common during in vitro culture (Goto et 
al., 1993).  
In vitro production of embryos has helped investigators define certain 
requirements for preimplantation embryo survival.  Studies have demonstrated that 
embryos cultured in atmospheric oxygen (20%) undergo cytoplasmic fragmentation and 
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eventually apoptosis due to a high concentration of ROS (Pabon et al., 1989; Yang et al., 
1998; Guérin et al., 2001).  Oxidative stress defined as “a disturbance in the 
prooxidant/antioxidant system” (Sies, 1995), is perhaps the leading cause of early 
embryonic loss, particularly during in vitro culture (Takahashi et al., 2000; Guérin et al., 
2001).   
In order to regulate the amount of ROS produced, many scientists began culturing 
embryos in a low oxygen atmosphere (5.0 – 7.5% O2) and adding antioxidants such as 
superoxide dismutase SOD (Umaoka et al., 1992), glutathione (review Takahashi et al., 
1993; Edwards et al., 2001; Mayor et al., 2001), and vitamins (Guérin et al., 2001).  
Mouse embryos cultured in high O2 with antioxidants, such as catalases or other O2 
scavengers, displayed an increased blastocyst development over embryos that did not 
receive supplemental antioxidants (Orsi and Leese, 2001).  Furthermore, an increase in 
apoptosis in bovine blastocysts was observed in a 20% oxygen atmosphere versus a 5% 
(Yuan et al., 2003).  However, when antioxidants were used during maturation of rat 
cumulus-oocyte complexes, resumption of meiosis was inhibited (Takami et al., 1999).  
Increasing concentrations of antioxidants during IVF significantly reduced oocyte 
penetration rates in bovine oocytes (Blondin et al., 1997).  A similar study performed in 
women undergoing IVF showed that women who became pregnant had higher follicular 
fluid ROS levels than those who did not; yet, the study also concluded that abnormally 
high ROS levels may indicate oxidative stress and prohibit conception (Attaran et al., 
2000).  Consequently, it appears that the presence of ROS during maturation and 
ovulation may be required, but excessive levels during embryo development may be 
detrimental.   
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A recent paper by Harvey and colleagues discusses REDOX (reduction-oxidation) 
regulation in preimplantation embryos as opposed to the actual amount of ROS present 
within the embryo environment (Harvey et al., 2002).  They defined the intracellular 
REDOX state as complex interactions of the relative concentrations of various oxidized 
and reduced molecules.  Extreme fluctuations in the REDOX state of a cell can alter the 
response of a number of genes and/or transcription factors, as well as transport systems 
like the cystine transport system, which influences intracellular glutathione levels (Dröge, 
2002).  ROS also serve as critical intracellular signaling molecules.   
Reactive oxygen species act as second messengers in signal transduction 
pathways (Finkel and Sullivan, 2000; Thannickal and Fanburg, 2000), and influence gene 
expression (Palmer and Paulson, 1997).  For instance, a family of proteins called stress-
activated protein kinases (SAPK), also known as c-Jun NH2-terminal kinase (JNK), and 
p38 are related to the members of the family of mitogen-activated protein kinases 
(MAPK).  Typically, MAPKs respond to growth factors and cytokines resulting in cell 
proliferation and differentiation.  SAPK respond to stressful stimuli, such as an altered 
redox state, and may participate in apoptosis (Ichijo, 1999).  SAPK belong to a family of 
proline directed serine-threonine kinases that respond to a stimulus by phosphorylation of 
their threonine and tyrosine residues; thus, altering its conformation resulting in kinase 
activity that activates transcription factors like nuclear factor κB (NF-κB) and activating 
protein 1 (AP-1), which play significant roles in cell survival (Hancock, 1999).   
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Role of Retinoids in Protecting the Early Embryo from Oxidative Stress 
Under certain conditions vitamin A and carotenoids participate in a biological 
antioxidant network.  Specifically, carotenoids can quench singlet oxygen molecules as 
well as interact with other antioxidant compounds (Olson, 1993; Packer, 1995).  
Retinoids may positively affect preimplantation embryonic development by various 
mechanisms such as inhibiting apoptosis, inducing and/or cooperating with antioxidant 
enzymes like superoxide dismutase (SOD), and catalase, and/or by increasing glutathione 
levels. 
Depending on the cell line, retinoids can be anti- or proapoptotic.  For example, in 
some cancerous cell lines retinoic acid has been shown to be proapoptotic (Chiba et al., 
1997; Hayden and Satre, 2002; Pratt and Niu, 2003).  On the other hand, several studies 
provide convincing evidence that retinoids suppress apoptosis in a number of tissues and 
cell lines by different mechanisms.  In mesangial cells exposed to hydrogen peroxide 
(H2O2), RA possessed anti-apoptotic effects by inhibiting JNK and activating protein-1 
(AP-1) (Moreno-Manzano et al., 1999).  AP-1 is composed of the heterodimers, c-Jun 
and c-Fos, which bind to particular cis-elements and initiate transcription of target genes.  
A follow-up study by the same lab illustrated the role of RARs and RXRs in the 
suppression of H2O2-induced mesangial apoptosis.  Again JNK and AP-1 were both 
involved.  In normal human bronchial epithelial cells (HBE), RA treatment inhibited JNK 
activity and reduced c-fos and protein levels by decreasing c-fos gene transcription.  In 
addition, agonists of retinoic acid receptors (RARs) and retinoid X receptors (RXRs) 
suppressed c-fos transcription (Lee et al., 1998).  Further experiments showed the anti-
apoptotic effect of RA was mediated by both receptor-dependent and receptor-
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independent mechanisms (Konta et al., 2001).  Another study demonstrated in HeLa cells 
that liganded RARs interfere with c-Jun/c-Jun homodimerization and c-Jun/c-Fos 
heterodimerization; thereby, preventing AP-1 complexes from binding to DNA and 
initiating apoptosis (Zhou et al., 1999). 
Protein kinase C (PKC) is a well-known enzyme that plays a significant role in 
signal transduction pathways.  It belongs to a family of serine/threonine kinases, and to 
date consists of eleven different isoforms, categorized as classic, novel, and atypical 
(Parekh et al., 2000).  These isoenzymes regulate a number of different processes such as 
cellular growth, differentiation, and apoptosis.  Retinol treatment of 3T3 cells enhanced 
the activation of PKCα in response to ROS by binding to its cysteine-rich domain (Imam 
et al., 2001).  Furthermore, investigators proposed a model describing how all-trans RA 
modulates the activity of PKCα in a line of cancer cells suggesting a pro-apoptotic role 
for RA (Radominska-Pandya et al., 2000).  So, it is possible that RA may impact the 
actions of other PKC isoforms that are anti-apoptotic.   
Another mechanism by which retinoids may exert their antioxidant effects is 
through modulation of antioxidants like SOD or catalase.  Treatment of hippocampal 
neurons with staurosporine, a chemical that induces apoptosis, reduced Mn-SOD and Cu-
Zn SOD levels; however, if the cells were pretreated with retinoic acid, protein levels of 
both types of SOD remained the same and apoptosis was prevented (Ahlemeyer et al., 
2001).  Mouse fetuses whose mothers were treated with retinoic acid showed decreased 
expression of apoptosis-related genes (Sarkar and Sharma, 2002). 
Retinoids may also impact oocyte and early embryonic development by 
modulating glutathione levels.  Glutathione (GSH) is the major non-protein sulphydryl 
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compound found in mammalian cells responsible for strong basal ROS scavenging 
activity (Dröge, 2002).  It is a tripeptide (γ-glutamyl, cysteinyl, glycine) that exists in two 
forms:  an oxidized form (GSSG) and a reduced form (GSH), which is the predominant 
form found in most tissues.  Intracellular glutathione synthesis begins with the 
transulfuration of homocysteine to cysteine, the major precursor for GSH synthesis 
(Deplancke and Gaskins, 2002).  Next, gamma-glutamyl cysteine synthetase (γ-GCS) 
combines L-glutamate and cysteine, followed by catalysis of glutamate-cysteine and 
glycine by glutathione synthetase.  γ-GCS is considered the rate-limiting enzyme in 
glutathione synthesis and its expression is increased under oxidizing conditions 
(Deplancke and Gaskins, 2002); yet, some believe that glutathione synthetase plays an 
equally important role (Huang et al., 2000).  Other important glutathione-related enzymes 
include glutathione peroxidase, which converts GSH to GSSG (Arai et al., 1999), 
glutathione reductase, which can reverse this reaction (Anderson, 1985), and glutathione 
S-transferase-pi (GSTp), which catalyzes the conjugation of GSH with deleterious 
compounds in order to protect the cell (Bernardini et al., 1999).   
Many oxidative stress-related enzymes, including those enzymes that regulate 
glutathione levels are found in the reproductive tract, its secretions, and even in the 
oocyte and early embryo (review El Mouatassim et al., 1999; Knappen et al., 1999).  For 
example, different levels of expression of GSH, GSSG, cysteine, and Mn-SOD were 
found in rabbit and rat embryos in different tissues (Hansen et al., 2001).  MII stage in 
vivo produced mouse and human oocytes expressed the following enzymes:  Cu-Zn SOD, 
MnSOD, GPx, and GCS (El Mouatassim et al., 1999).  GSTp was found in human 
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ovarian follicular fluid, and this particular isoform is also important in placental function 
(review Knappen et al., 1999).   
Several reports highlight the importance of having adequate glutathione levels in 
both oocytes and early embryos.  Levels of glutathione vary depending on the embryonic 
stage, and evidence suggests that gonadotropins may affect glutathione synthesis in the 
rat ovary by altering levels of key synthetic enzymes (Luderer et al., 2001).  For instance, 
intracytoplasmic levels of glutathione in bovine embryos derived in vitro were lowest at 
the 2-8 cell stage, increased during the 9-16 cell stage, and reached their highest levels at 
the hatched blastocyst stage (Lim et al., 1996).  In hamster oocytes, the GSH content 
doubled after germinal vesicle breakdown, remained high until after metaphase II, and 
decreased after fertilization (Zuelke et al., 2003).   
Gardiner and colleagues reported the presence of glutathione in mouse oviduct 
flushings, and if the embryos were deprived of GSH, blastocyst development was 
retarded compared to embryos that received exogenous GSH (Gardiner et al., 1998).  
Glutathione addition to caprine oocyte maturation medium increased the GSH content of 
oocytes, but did not increase the fertilization rate (Mayor et al., 2001).  If an inhibitor of 
glutathione synthesis, buthionine sulfoximine (BSO), was added to the culture medium 
containing 6-8 cell bovine embryos, blastocyst development was compromised 
(Takahashi et al., 1993).  Further studies confirmed the beneficial effects of higher GSH 
levels in oocyte maturation medium (bovine, mouse, pig) on subsequent embryo 
development (Luvoni et al., 1996; Furnus et al., 1998; Knappen et al., 1999; de Matos 
and Furnus, 2000; Shi et al., 2000; Brad et al., 2003).  Glutathione is also necessary for 
the transformation of the disulfide rich sperm nucleus into the male pronucleus at 
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fertilization (Calvin et al., 1986; Perreault et al., 1988; Yoshida et al., 1993).  Another 
beneficial effect of glutathione is its potential ability to protect early embryos from heat 
stress (Ealy et al., 1992; Edwards et al., 2001).   
Thiol compounds, particularly cysteine are required for glutathione synthesis 
(Knappen et al., 1999), and researchers have utilized these precursors to investigate their 
effect on in vitro embryonic development.  For example, Takahashi and coworkers 
concluded that addition of two thiol compounds, ß-mercaptoethanol (ß-ME) and 
cysteamine, to 6-8 cell bovine embryos improved development to the blastocyst stage 
(Takahashi et al., 1993).  Whenever ß-ME, cysteine, or cystine was added to maturation 
medium containing bovine oocytes, blastocyst development significantly increased over 
the control oocytes that did not contain these glutathione precursors (de Matos and 
Furnus, 2000).  Cysteamine addition during oocyte maturation of several species 
improved significantly embryonic development, as assessed by progression to the 
blastocyst stage (Gasparrini et al., 2000; de Matos et al., 2002; de Matos et al., 2003).  
One study cultured bovine embryos in a 5% oxygen atmosphere in the presence of 
cysteine, and found this increased the number of cells located in the inner cell mass.  
However, the same study discovered that cysteine addition was detrimental to blastocyst 
rates and hatching rates (Van Soom et al., 2002).   
Evidence exists that retinoids may modulate glutathione levels.  Retinoic acid 
inhibited the depletion of glutathione in cultured neuron cells that were treated with 
staurosporine; thus, preventing oxidative damage and apoptosis (Ahlemeyer and 
Krieglstein, 2000).  A retinoic acid response element (RARE) was found in the promoter 
region of a specific isoform of GSTp in a glioblastoma cell line (Lo and Ali-Osman, 
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1997), and in glutathione peroxidase – Gpx2 (Chu et al., 1999).  Additionally, a study 
provided evidence that retinoic acid modulated glutathione, glutathione peroxidase, and 
glutathione reductase levels (Texeira et al., 1996). 
 
SUMMARY 
With an increase in embryo manipulation and IVF produced animals it is 
imperative that embryo viability assays be developed (Overström, 1996; review 
Overström, 2000).  Manipulation of mammalian embryos before implantation has risen 
over the last 10-15 years due to the economic and social pressures placed on the 
commercial production of animals to produce more milk, meat, and overall genetic gain 
(Van Soom and de Kruif, 1996).  Experimental manipulation of human oocytes and 
embryos (i.e. intracytoplasmic sperm injection – ICSI and cytoplasmic transfer) has also 
increased significantly over the last decade.  The potential benefits of techniques like in 
vitro fertilization (IVF) and culture include helping infertile couples conceive, rescuing 
oocytes from women undergoing clinical procedures that place oocytes at risk, and 
enlarging the endangered wildlife population (Eppig et al., 1996).  Even though much 
research has focused on what influences an oocyte/embryo’s developmental competence, 
it is still not clear what factors are specifically needed for an embryo to become a 
blastocyst or viable offspring.  Furthermore, several laboratories have demonstrated that 
many stressors impact embryo survival, especially during in vitro culture (review Lane, 
2001).   
Vitamin A (retinol) is essential for reproduction (Ganguly, 1989; Gudas et al., 
1994; Maden, 2000), and the natural metabolites of retinol, all-trans retinoic acid (RA) 
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and 9-cis RA, are recognized as important signaling molecules in differentiation and 
development of many cell and organ systems (Blaner and Olson, 1994; Gudas et al., 
1994).  Recent evidence indicates that retinol and RA influence follicular development 
and oocytes maturation in vivo and in vitro.  Retinol administration to sheep and cattle, in 
combination with superovulation and followed by insemination, was shown to improve in 
vitro developmental competence of resultant embryos in the former and embryo quality 
in the latter (Blaner and Olson, 1994; Gudas et al., 1994; Shaw et al., 1995; Eberhardt et 
al., 1999b).  Retinol administration to swine has been reported to advance resumption of 
meiosis, alter follicular hormone concentrations (Whaley et al., 2000) and increase litter 
size in some, but not all, studies (Coffey and Britt, 1993; Pusateri et al., 1999).  In vitro, 
addition of retinol to oocyte maturation and embryo culture medium was observed to 
improve developmental competence of bovine embryos (Livingston et al., 2002).  
Retinoic acid administration to meiotically blocked bovine oocytes promoted cytoplasmic 
maturation and enhanced their developmental capacity (Duque et al., 2002).   
The objectives of this research were to further characterize the beneficial effects 
of retinol during oocyte maturation and embryonic development, to evaluate the role of 
retinol on sheep oocyte metabolism, and to help elucidate its mechanism of action in the 
oocyte and embryo via oxidative stress signaling pathways.  This will help facilitate the 
identification of factors that not only influence, but also improve an embryo’s ability to 
survive excessive handling, such as in vitro culture, cryopreservation, and embryo 
transfer, which are areas of great importance in both basic and applied reproduction 
practices. 
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CHAPTER 2 
 
Metabolism of Sheep Oocytes During In Vitro Maturation 
 
 
ABSTRACT 
 
The purpose of the present study was to evaluate energy metabolism during in 
vitro maturation (IVM) of individual ovine oocytes and to determine effects of in vivo 
retinol administration on this process.  Ewes were superovulated with FSH and treated 
with retinol or vehicle.  Oocytes were subjected to metabolic measurements during 
during early (0-3 hours), mid (9-12 hours), or late (21-24 hours) stages of IVM using 
hanging-drop procedures.  The substrates 5-3H glucose, 1-14C and 6-14C glucose, 2-14C 
pyruvate, and 3,4 3H glutamine were used to evaluate metabolism.  Results showed that 
glucose metabolism through the glycolytic pathway changed from early to mid time 
periods (0.24 to 21.65 pmoles/oocyte/3hours; p < .02), and early to late time periods 
(0.24 to 14.24; p < .01).  Glucose oxidation through the Krebs cycle did not change 
significantly over the twenty-four hour maturation time period (0.29 to – 0.61), and 
likewise, glucose metabolism via the pentose-phosphate pathway did not change during 
IVM.  Oxidative metabolism measured by glutamine showed no significant differences 
over all time periods.  Pyruvate oxidation was highest early in maturation and then 
decreased (3.14 to 1.44; p < .14).  Glutamine oxidation appeared to be most active early 
and then declined.  Glycolysis was highest at the middle time period.  These results 
suggest that ovine oocytes use both glycolysis and oxidative pathways throughout IVM. 
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No significant differences existed between oocytes from retinol-treated ewes and control 
oocytes. 
 
 
INTRODUCTION 
Preimplantation embryo development is strongly affected by the follicular 
environment in which the oocyte grows and matures.  Upon completion of oogenesis an 
oocyte is arrested in the dictyate stage of prophase I.  In vivo, the preovulatory surge of 
gonadotropins, via communication with the granulosa cells induces resumption of 
meiosis and release of the oocyte from the follicle.  However, physical release of the 
oocyte followed by in vitro maturation (IVM) also triggers meiosis to resume (Eppig et 
al., 1996; Driancourt and Thuel, 1998; Duranthon and Renard, 2001).  Oocyte maturation 
may be divided into two distinct yet equally important processes:  nuclear and 
cytoplasmic maturation.  Nuclear maturation refers to the progression of meiosis from 
prophase I to metaphase II before fertilization (Xu et al., 1986; Dominko and First, 1997).  
Cytoplasmic maturation involves redistribution of mitochondria and changes in ATP 
content (Stojkovic et al., 2001), structural changes such as cortical granule realignment 
(De Loos et al., 1992; Abbot and Ducibella, 2001), and other organelle rearrangments 
(De Loos et al., 1992).  The timing and assessment of meiotic and cytoplasmic 
maturation have been characterized in domestic animals, humans, and rodents (Sorensen 
and Wassarman, 1976; Xu et al., 1986; Dominko and First, 1997; Hunter, 2000; 
Combelles et al., 2002); however, this developmental process is still not completely 
understood.   
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In order to better understand and improve in vitro maturation and culture 
conditions, studies have been performed using different combinations of nutrients, energy 
sources, hormones, and growth factors.  Results from these numerous studies have 
demonstrated that an oocyte requires certain substrates in order to successfully complete 
both nuclear and cytoplasmic maturation (Downs and Mastropolo, 1994; Eppig et al., 
1994; Downs and Mastropolo, 1997); (Izadyar et al., 1998), and after fertilization 
complete early embryonic development. 
Investigation of oocyte and early embryo metabolism (Leese and Barton, 1984; 
Rieger and Loskutoff, 1994; Downs and Utecht, 1999; Spindler et al., 2000) has led to 
the identification of important substrate requirements and better culture conditions.  More 
recently, certain metabolic events have been linked with better viability after transfer 
(Krisher and Bavister, 1999; Spindler et al., 2000) and cryopreservation (Gardner et al., 
1996).  For example, it has been reported that mouse blastocysts with lower glycolytic 
rates are more viable after transfer (Lane and Gardner, 1996), while others have 
concluded that higher glycolytic rates in oocytes are more indicative of developmental 
competence (Krisher and Bavister, 1999; Spindler et al., 2000). 
Using both fluorescent and radioactive labeling techniques, numerous metabolic 
studies have been conducted in preimplantation domestic embryos.  For instance, non-
invasive metabolic measurements of bovine embryos in vitro demonstrated a dependence 
on oxidative phosphorylation until compaction, after which a shift towards glycolysis was 
observed (Thompson et al., 1996).  In vivo produced sheep embryos prefer pyruvate as 
their primary substrate from fertilization until the blastocyst stage (Gardner et al., 1993).  
Radioactive labeling of glucose in sheep embryos showed no difference in glycolysis 
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between in vivo versus in vitro derived embryos, but differences in glucose oxidation 
were observed (Thompson et al., 1991).  A later study also described how culture 
conditions alter glucose utilization by early sheep embryos (Thompson et al., 1992); thus, 
many different factors may influence the metabolism of early embryos.   
Vitamin A (retinol) is essential for reproduction (Ganguly, 1989; Gudas et al., 
1994; Maden, 2000), and the natural metabolites of retinol, all-trans retinoic acid (RA) 
and 9-cis RA, are recognized as important signaling molecules in differentiation and 
development of many cell and organ systems (Blaner and Olson, 1994; Gudas et al., 
1994).  Recent evidence indicates that retinol and RA influence follicular development 
and oocytes maturation in vivo and in vitro.  Retinol administration to sheep and cattle, in 
combination with superovulation and followed by insemination, was shown to improve in 
vitro developmental competence of resultant embryos in the former and embryo quality 
in the latter (Blaner and Olson, 1994; Gudas et al., 1994; Shaw et al., 1995; Eberhardt et 
al., 1999b).  Retinol administration to swine has been reported to advance resumption of 
meiosis, alter follicular hormone concentrations (Whaley et al., 2000) and increase litter 
size in some, but not all, studies (Coffey and Britt, 1993; Pusateri et al., 1999).  In vitro, 
addition of retinol to oocyte maturation and embryo culture medium was observed to 
improve developmental competence of bovine embryos (Livingston et al., 2002).  
Retinoic acid administration to meiotically blocked bovine oocytes promoted cytoplasmic 
maturation and enhanced their developmental capacity (Duque et al., 2002).   
The actions of retinoids are mediated through two groups of nuclear receptors, 
retinoic acid receptors (RARs) and retinoic X receptors (RXRs) (review Mangelsdorf et 
al., 1994).  Retinoid-receptor complexes affect gene activation or inactivation through 
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association with specific response elements (RAREs) found in the promoter regions of 
target genes.  Messenger RNA and gene products for several of the retinoic acid nuclear 
receptors have been identified in bovine oocytes and early embryos (Mohan et al., 2002) 
demonstrating that the functional machinery for retinoid signaling is present. 
Although it is clear from our previous studies and others that retinoids influence 
oocyte maturation and embryonic development, the mechanisms involved have yet to be 
determined.  The first goal of this study was to determine the metabolic requirements of 
sheep oocytes during different time periods of IVM.  The second aim was to evaluate the 
effects of retinol on the oocyte’s metabolism and nuclear development in vitro.  As in 
previous studies (Rieger and Loskutoff, 1994; Downs and Utecht, 1999; Spindler et al., 
2000), we assessed sheep oocyte metabolism using a combination of radiolabeled 
substrates.  The production of 3H2O from 5-3H glucose measures the glucose uptake by 
the Embden-Meyerhof pathway.  This was determined by one study where a tritium 
radiolabel was used to trace the fate of each glucose hydrogen during glucose metabolism 
and recycling (Russell and Young, 1990).  Earlier experiments demonstrated that release 
of 14CO2 from 1-14C glucose is cycled through glycolysis, Krebs cycle, and the pentose 
phosphate pathway (PPP) (Katz and Wood, 1963).  In addition, the same study showed 
that metabolism of 6-14C glucose measures the amount of glucose utilized by glycolysis 
and also by the Krebs cycle.  The evolution of 3H2O from the consumption of 3,4 3H 
glutamine and 14CO2 release from 2-14C pyruvate also measures the activity of the Krebs 
cycle.   
Results from the present study indicate that sheep oocytes utilize different 
substrates and metabolic pathways over the course of IVM.  Furthermore, we did not 
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observe a difference in metabolism between oocytes from retinol-treated ewes versus 
oocytes from control ewes. 
 
 
MATERIALS AND METHODS 
Materials 
 All chemicals were purchased from Sigma Chemical Company, St. Louis, MO 
unless otherwise noted.  Mature cross-bred ewes were provided by the University of 
Tennessee, Knoxville Experiment Station.  Progestin-impregnated vaginal implants 
(CIDR-G) were purchased from InterAg, Hamilton, New Zealand.  Lutalyse 
(prostaglandin F2α) was purchased from Pharmacia & Upjohn Co. (Kalamazoo, MI), and 
follicle stimulating hormone (FSH) was purchased from Sioux Biochemical, Sioux 
Center, IA.  Embryo collection media was composed of modified M199, 4.2 mM 
NaHCO3, 10 mM HEPES, and 50 µg/mL heparin.  Fetal bovine serum (FBS) used in 
embryo collection medium was purchased from BioWhittaker, Baltimore, MD, and 
glutamine and penicillin/streptomycin were purchased from Specialty Media, 
Phillipsburg, NJ.  Oocyte maturation medium (OMM) contained M199 and 50 µg/mL of 
gentamycin, purchased from Specialty Media, 5 µg/mL of FSH purchased from 
Vetrepharm Canada, Inc. (Ontario, Canada), 0.3 µg/mL of lutenizing hormone (LH) that 
was generously provided by the USDA, Beltsville, MD., 10% FBS, 0.2 µM sodium 
pyruvate and 2 mM glutamine.  Scintillation fluid (Ultima Gold XR) was purchased from 
Packard Instrument Co., Meriden, CT. 
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Radioactive Substrates 
D-[5-3H] glucose was purchased from Amersham Pharmacia Biotech, 
Buckinghamshire, England (1.0 mCi/mL with a specific activity of 77.3 mCi/mg).  D-1 – 
14C glucose (1.0 mCi/mL; 54.3mCi/mmol) and D-6-14C glucose (1.1 mCi/mL; 
56mCi/mL) were purchased from Sigma.  Pyruvic acid [2-14C] and Glutamine L-[3,4-
3H(N)] were both purchased from New England Nuclear Life Science Products, Boston, 
MA.  Pyruvic acid was purchased in a solid form, and its specific activity was 15.8 
mCi/mmol.  The concentration of glutamine was 1.0 mCi/mL and its specific activity was 
49.9 mCi/mL.  The substrates had a final concentration of 0.25 µCi/µl except for 2-14C 
pyruvate, which was 0.079 µCi/µl.  The final concentrations of the labeled plus unlabeled 
substrates were as follows:  glucose (5.5 mM), glutamine (2 mM) and pyruvate (0.2 mM).  
The 3H2O and NaH14CO3 used to calculate the recovery efficiency were both purchased 
from Sigma. 
 
Embryo Collection  
Mature cross-bred ewes were synchronized with CIDR-G implants.  Lutalyse 
was administered 6 days after the CIDR was implanted.  FSH was administered four days 
after prostaglandin injections in decreasing doses, twice daily for three days (5 IU, 4 IU, 
3 IU).  On the first and last morning of FSH injections each ewe was also administered 
500,000 IU of all-trans retinol dissolved in corn oil.  Control ewes received only vehicle 
(corn oil).  Implants were left in place until after the ovaries were collected in order to 
prevent a premature LH surge.  All animals were maintained on high-quality hay and fed 
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ad libitum, with free-choice access to a sheep and goat mineral premix that contained 1 
million IU vitamin A per pound. 
Ewes were ovariectomized and their cumulus oocyte complexes (COCs) were 
recovered by slicing only healthy, large follicles (>5mm).  The COCs were randomly 
allocated to different groups, each representing one of the three different time periods  
(0-3, 9-12, 21-24).  The oocytes that were not subjected to a metabolic measurement 
during the first time period were placed in a four-well plate with 500 µl of preequilibrated 
(38.5°C, 5% CO2 in air) OMM.  Immediately prior to the metabolism measurement, 
oocytes were denuded by gentle pipetting with 20% hyaluronidase, and then washed 
three times in preequilibrated (38.5°C, 5% CO2 in air) metabolic measurement medium 
(MMM), which was OMM minus FBS.  This was repeated for every time period. 
 
Metabolism Assay 
Sheep oocyte metabolism was measured using a modified hanging-drop technique 
(Rieger and Guay, 1988).  Microcentrifuge tubes were filled with 600 µl of 25mM 
NaHCO3 and preequilibrated for at least one hour at 38.5°C, 5% CO2 in air.  Individual 
washed oocytes were loaded in 2 µl of MMM, placed on the cap of a microcentrifuge 
tube, and then 2 µl of the radiolabeled metabolic substrates were added to the cap.  Lids 
were gently closed and the tubes placed in the incubator for three hours.  The NaHCO3 
acts as a trap for 14CO2 and 3H2O released by the oocyte.  Sham and total count tubes 
were also incubated with oocytes from each ewe.  The sham tubes contained 2 µl of the 
MMM and 2 µl of the radiolabel without an oocyte.  These accounted for any nonspecific 
counts including machine background, bacterial contamination, chemiluminescence, or 
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the spontaneous breakdown of the metabolic substrates.  Total count tubes contained 2 µl 
of the radiolabeled substrates added directly to the NaHCO3.   
After the three-hour metabolism period, tubes were removed, and oocytes were 
washed and stained in order to assess their meiotic stage.  The NaHCO3 was immediately 
mixed with 4 mL of scintillation fluid and counted in a liquid scintillation counter 
programmed for dual-label counting of 14C and/or 3H.  In order to determine mean 
radioactivity that each oocyte utilized, counts from the sham tube were subtracted from 
the tube containing the oocyte.  This difference was divided by total radioactivity of 
labeled substrate added, and multiplied by the total quantity of substrate (labeled plus 
unlabeled) in 4µl of medium.  This number was then multiplied by the recovery 
correction factor (Rieger and Loskutoff, 1994).  In order to calculate the recovery 
efficiency of our system both 3H2O and NaH14CO3 were utilized.    Three different 
concentrations (0.08, 0.25, 0.5 µCi/µl) were used over three days at each of the different 
time periods.  The recovery values for our system were 1.14 and 1.12 for 3H2O and 
NaH14CO3, respectively.   
 
Staining 
In order to determine meiotic stage, oocytes were stained with Hoechst dye.  
Briefly, each oocyte was placed in approximately 500 µl of 50 µg/ml of bisbenzamide 
(Hoechst 33258; Sigma) dissolved in HEPES-TALP.  The dish was placed under a cover 
away from light for 20 minutes, and then the oocytes were washed to remove excess dye 
and viewed with a 100X objective under UV light. 
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Data Analysis 
 Data were checked for normality, log transformed, and analyzed using an 
incomplete block design blocked on replication with analysis of variance (ANOVA) 
using mixed model ANOVA methods in SAS (2000).  Main effects and all interactions of 
substrate, time and treatment were tested.  Differences were detected using Fisher’s 
protected least significant difference.  The means reported are untransformed.  A 
probability of p<.05 was considered significant for all statistical tests.  Differences due to 
retinol treatment were not detected; therefore, data from retinol treated and control 
oocytes were combined. 
 
RESULTS 
 Oocytes were collected from superovulated, retinol or vehicle-treated ewes, and 
their metabolism was measured in vitro at three separate time points over a twenty-four 
hour maturation period.  Glucose metabolism through the glycolytic pathway (5-3H 
glucose) dramatically increased from 0.24 to 21.65 pmol/oocyte/3hr (p<.03) from the 
early measurement (0-3 hours) to the middle measurement (9-12 hours), then dropped to 
15 pmol/oocyte/3hr at the last time period (21-24 hours) (p<.001).  During the first three 
hours of maturation oocytes consumed significantly more 3,4 3H glutamine compared to  
5-3H glucose (15.18 vs 0.24; p<).  Glutamine metabolism did not significantly change 
until the last time period (21-24 hours) when it dropped from 20.22 pmol/oocyte/3hr at 9-
12 hours to 7.42  pmol/oocyte/3hr (Figure 2-1) 
 Figure 2-2 illustrates metabolism of 14C substrates for all oocytes, regardless of 
treatment.  Pyruvate oxidation, measured by 2-14C pyruvate uptake, remained essentially 
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Figure 2-1.  The metabolism of 5-3H glucose and 3,4-3Hglutamine by sheep oocytes.  
Individual sheep oocytes were measured at specific time periods during maturation( 0-3, 
9-12, and 21-24 hours).  Lower case letters indicate differences within the same substrate 
(p<.05).  Uppercase letters indicate differences across substrates (p<.05).  The number of  
oocytes measured in a given time period is represented as (n). 
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Figure 2-2.  The metabolism of 1-14C glucose, 6-14C glucose, and 2-14C pyruvate by 
sheep oocytes.  Individual sheep oocytes were measured at specific time periods during 
maturation( 0-3, 9-12, and 21-24 hours).  Lower case letters indicate differences within 
the same substrate (p<.05).  Upper case letters indicate differences across substrates 
(p<.05).  The number of oocytes measured in a given time period is represented as (n). 
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the same throughout the entire maturation period until the last time frame when a 
decrease was observed.  From 0-3 hours oocytes consumed 3.14 ± 0.61 pmol/oocyte/3hr 
of pyruvate, from 9-12 hours they consumed 2.75 ± 0.61 (p<.01), and during the last time 
period pyruvate metabolism dropped to 1.44 ± 0.58 pmol/oocyte/3hr.  These values were  
all significantly higher than the other 14C labeled substrates at all time periods (p<.001).  
Glucose flow through the PPP (indicated by 1-14C glucose) was below 1.0 
pmol/oocyte/3hr at all time periods as was glucose flux through the Krebs cycle as 
indicated by the metabolism of 6-14C glucose.   
The effect of retinol on the metabolism of each oocyte was examined by 
analyzing differences between metabolism of control oocytes and oocytes from retinol-
treated ewes, during the same time period within the same substrate.  No significant 
differences existed (data not shown). 
Meiotic stage was also assessed for each oocyte (data not shown).  Kinetics of 
meiotic progression from germinal vesicle breakdown (GVBD) to metaphase II (MII) 
was consistent regardless of the substrate or retinol treatment.  After three hours of 
maturation greater than 90% of the oocytes had progressed to GVBD, after 12 hours they 
had reached MI, and by 24 hours 70% of the oocytes had progressed to MII. 
 
DISCUSSION 
Little information exists concerning sheep oocyte metabolism.  Only a few studies 
have examined the metabolism of in vivo matured sheep oocytes (Butler and Williams,                              
 44
1991; Butler and Williams, 1992; Gardner et al., 1993), and to our knowledge, this is the 
first in-depth investigation of metabolism of single ovine oocytes over the entire IVM 
period.  We examined the activities of different energy pathways (glycolysis, Krebs, and 
PPP) of immature and in vitro matured sheep oocytes using different combinations of 
radiolabeled substrates.   
Several studies have measured individual oocyte metabolism.  Early work in the 
mouse indicated that a denuded mouse oocyte prefers pyruvate as an energy source 
(Biggers et al., 1967).  Later studies confirmed that pyruvate is essential during mouse 
oocyte maturation, and it is preferred over glucose (Leese and Barton, 1984; Downs et 
al., 2002).  During in vitro maturation of bovine oocytes there is a dependence on 
pyruvate, but unlike their mouse counterparts, bovine oocytes utilize glucose as well 
(Rieger and Loskutoff, 1994; Krisher et al., 1999).  Studies performed on cat oocytes 
have demonstrated that these oocytes utilize both glycolysis and oxidation of glucose, 
glutamine, palmitate, and lactate (Spindler et al., 2000). 
In our study, glycolysis values, as indicated by 5-3H glucose utilization during the 
initial IVM time period (GVBD), were similar to other reported values for denuded 
oocytes (Rieger and Loskutoff, 1994; Gandolfi et al., 1998; Krisher and Bavister, 1999; 
Spindler et al., 2000).  We observed a dramatic increase in glycolytic metabolism during 
the middle time period when oocytes reach MI, and then a decrease at the 21-24 hour 
time period as they reach MII.  Glucose uptake, measured by fluorescence techniques in 
unfertilized sheep ova was consistent with our measurement during the last time period 
(Butler and Williams, 1992).  In contrast, Gardner and colleagues found a much lower 
glucose uptake in unfertilized sheep ova (Gardner et al., 1993).  Only one other study has 
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evaluated metabolism during the entire maturation period, and that was in bovine oocytes 
(Rieger and Loskutoff, 1994).  Results from this study were different.  Specifically, their 
measurements of bovine oocyte glycolysis were consistently low over the entire 
maturation period, and higher levels of pyruvate metabolism were observed.  However, 
the concentration of pyruvate used was more than ten times higher than the concentration 
we used.  Since another report showed that decreased levels of pyruvate uptake in bovine 
oocytes increased glucose utilization via glycolysis (Krisher and Bavister, 1999), this 
may explain the discrepancy between the two studies.  Another possibility includes 
species differences between the cow and sheep. 
Gonadotropin stimulation may also impact the metabolism of 5-3H glucose, as 
suggested in a study comparing gonadotropin-primed and non-primed mice (Downs and 
Utecht, 1999).  Since the oocytes in our study were recovered from superovulated ewes, 
this may contribute to differences between our study and others.  In addition, higher 
glycolytic rates may also indicate a hypoxic environment, which limits the use of 
pyruvate (Leese, 1991).  However, this seems unlikely since the oocytes in the present 
study were matured under atmospheric oxygen conditions. 
Oxidation of glucose is measured by the flux of 1-14C glucose and 6-14C glucose 
through the Krebs cycle.  Furthermore, the carbon of the 1-14C glucose is also 
metabolized via the pentose phosphate pathway (PPP).  One study suggests that the PPP 
is necessary for meiotic induction to occur in the presence of FSH (Downs and Utecht, 
1999).  In our study utilization of both 1-14C glucose and 6-14C glucose are low 
throughout the maturation period, which is consistent with results for bovine oocytes 
(Rieger and Loskutoff, 1994).    Proper meiotic progression occurred regardless of the 
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substrate utilized in our study.  Since oxidation of glucose was similar for 1-14C glucose 
and 6-14C glucose at the middle and early time periods, it can be assumed that both 
pathways, Krebs and PPP, were being used.  During the last time period values for 1-14C 
glucose were slightly higher than 6-14C glucose, perhaps indicating more flux through the 
PPP than through the Krebs cycle. 
Labeled 3H-glutamine and 14C-pyruvate are also indicators of oxidative 
metabolism through the Krebs cycle.  We observed that glutamine oxidation during the 
early stages of IVM (GVBD) was higher than both glucose and pyruvate uptake.  Bovine 
oocytes showed lower uptake of glutamine, singly radiolabeled with tritium, than in our 
study (Rieger and Loskutoff, 1994), but when glutamine was uniformly labeled with 14C 
(Gandolfi et al., 1998), glutamine oxidation increased, although still lower than our 
values.  When bovine cumulus oocyte complexes were matured in the presence of 
lutenizing hormone (LH), the denuded oocytes exhibited higher levels of glutamine 
metabolism (Zuelke and Brackett, 1993).  In our study we added additional LH in 
conjunction with what is present in the fetal bovine serum.  Perhaps this extra LH played 
a role in our higher levels of glutamine oxidation. 
Published values for oocyte pyruvate oxidation over the entire maturation period 
vary greatly, from slightly over 1 pmol/oocyte/3hr (Krisher and Bavister, 1999) to over 
30 pmol/oocyte/3hr (Gardner et al., 1993).  Values from this study fall within the 
reported ranges.  Some studies have observed that oocytes preferentially utilize pyruvate 
over glucose during maturation (Rushmer and Brinster, 1973; Leese and Barton, 1984; 
Rieger and Loskutoff, 1994; Gandolfi et al., 1998; Krisher and Bavister, 1999; Spindler 
et al., 2000).  We too observed that pyruvate utilization during early stages of IVM was 
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higher than that of 5-3H glucose. Using a microfluorescence technique, Gardner and 
colleagues examined pyruvate metabolism of mature oocytes collected from the oviducts 
of ewes.  They determined that the pyruvate uptake was 32 pmol/oocyte/3hr (Gardner et 
al., 1993).  In contrast, Butler and Williams, using the same technique, reported much 
lower values for pyruvate uptake by unfertilized ovine ova (Butler and Williams, 1991).  
Although our results for an in vitro matured oocyte differ from these two papers, the 
techniques employed may explain some of the dissimilarities (Barnett and Bavister, 
1996).  In addition, metabolic requirements for in vivo derived oocytes have been shown 
to be different from their in vitro matured counterparts (Mermillod et al., 1999; 
Overström, 2000; Rizos et al., 2002).  For example, a report by Khurana and Niemann 
concluded that glucose metabolism by in vitro produced bovine embryos was two-fold 
higher than their in vivo counterparts (Khurana and Niemann, 2000).  The buffering 
system (HEPES versus NaHCO3) employed may alter the metabolic activity of the 
oocyte, further explaining discrepancies among different studies (Barnett and Bavister, 
1996).   
This study was the first to evaluate sheep oocyte metabolism over the entire 
maturation period.  Metabolism was chosen as a parameter because it can serve as an 
indicator of an oocyte’s health, and it has been shown that altered oocyte metabolism 
impacts embryo development (Bavister, 1995; Downs and Utecht, 1999; Krisher and 
Bavister, 1999; Spindler et al., 2000).  We found differences between various substrates 
during the same time period as well as between different time periods.  In vitro-matured 
sheep oocytes preferentially utilized oxidative pathways during early stages of IVM 
(GVBD) as indicated by elevated levels of glutamine oxidation.  In contrast to bovine 
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oocytes, glucose metabolism during the middle time stage, when oocytes are 
predominately at MI, was almost entirely derived from glycolysis.  However, during this 
same time period glutamine oxidation also remained high, suggesting the oocytes utilized 
both pathways.  Glutamine oxidation significantly decreased by the 21-24 hour time 
period, when oocytes reach MII, as did 5-3H glucose metabolism.  Unlike their bovine 
counterparts, sheep oocytes seemed to prefer glucose to pyruvate.  The concentration of 
substrates and metabolic pathways a denuded oocyte uses may vary greatly from the 
requirements of a cumulus-enclosed oocyte.  In addition, since we know IVM conditions 
are not optimal, these measurements provide only an indication of what substrates and 
metabolic pathways a sheep oocyte may utilize. 
The present study was also performed in order to determine if in vivo retinol 
administration impacted in vitro oocyte metabolism.  Earlier studies from our laboratory 
demonstrated that embryos collected from retinol-treated, superovulated ewes had a 
higher blastocyst developmental rate than did embryos collected from vehicle-treated 
ewes when cultured in vitro (Eberhardt et al., 1999b).  In the same study, it was observed 
from retinol-treated ewes embryos were more competent to progress beyond the 8-16 cell 
block (Telford et al., 1990) than control embryos.  Since maternal factors stored in the 
egg are recognized to influence the embryo before and after zygotic gene activation 
(Blondin and Sirard, 1995; Eppig et al., 1996; De Sousa et al., 1998), and the treatment 
was administered prior to ovulation, it was hypothesized that retinol exerted its affect on 
the maturing oocyte.  However, no significant differences were observed for oocytes 
from retinol-treated ewes versus oocytes collected from control ewes.  Hence, it is 
concluded that the retinol treatment imposed did not affect oocyte metabolism, overall.  
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Yet, we are cognizant of the fact that the metabolism assay may not have been 
sufficiently sensitive to detect differences.  The more likely explanation is that positive 
effects of retinol administration during the final stages of follicular development may be 
manifested in the embryo, after fertilization.  Demonstration of this will require further 
study and experiments are currently being conducted. 
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CHAPTER 3 
 
 
The Effects of Retinol Supplementation on Bovine Embryo 
Development In Vitro 
 
 
ABSTRACT 
 
Retinoids are recognized as important regulators of vertebrate development, cell 
differentiation, and tissue function.  Previous studies demonstrated that retinol 
administration to ewes, followed by natural service, resulted in embryos with improved 
competence to develop in vitro.  The present study evaluated the in vitro effects of retinol 
addition to media containing maturing oocytes and developing embryos.  Bovine oocytes 
were matured in the presence or absence of varying concentrations of retinol.  After a    
22-24 hour maturation period the oocytes were fertilized, denuded 18 hours later and 
cultured in a modified synthetic oviductal fluid (mSOF) in a humidified atmosphere at 
38.5°C, 5.5% CO2, 7% O2.  Cleavage rates as well as the number of eight-cell embryos 
did not differ between the control and retinol-treated oocytes.  The addition of 5µM 
retinol to the maturation medium (IVM) tended to increase blastocyst formation 
(blastocyst/putative zygote; 26.1 ± 2.2) compared to the controls (21.9 ± 1.9; p=.07).  
Cell numbers of day 8 blastocysts did not differ significantly between the two treatments 
(control, 73.55; 5µM, 79.6).  Further analysis revealed when the blastocyst rate fell below 
20% in the control group, the 5µM retinol treatment dramatically improved embryonic 
development, measured by blastocyst/putative zygote rate (14.4 ± 2.1 vs 23.7 ± 2.5; 
p<.02).  The 5µM retinol treatment also enhanced the blastocyst/cleaved rate by nearly 
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10% (23.7% vs 34.6%; p<.02).  The addition of retinol to the embryo culture medium 
(IVC) did not significantly improve cleavage rates, percent eight-cell, or blastocyst rates, 
but 5µM retinol significantly increased blastocyst cell number (72.16 ± 5.25 vs 84.78 ± 
5.25; p<.03).  When 10µM retinol was added to embryos in mSOF, it was detrimental to 
blastocyst development (25.92% vs 13.92%; p<.002).  These studies demonstrate that 
supplementation of 5µM retinol to the maturation medium may improve embryonic 
development of bovine oocytes indicated by their increased blastocyst rate, and 5µM 
retinol addition to the culture medium may improve blastocyst cell number.   
 
INTRODUCTION 
Vitamin A (retinol) and its bioactive metabolite, retinoic acid (RA), are essential 
for reproductive success in both males (Juneja et al., 1966; Jayaram et al., 1973; Livera et 
al., 2000) and females (Bagavandoss and Midgley, 1988; Keenan, 1997).  These 
lipophilic compounds influence many reproductive steroid hormones such as 
gonadotropin releasing hormone (Lefèvre et al., 1994), lutenizing hormone and follicle 
stimulating hormone (Lefèvre et al., 1994; Minegishi et al., 2000).  Normal embryonic 
development also requires a precise, physiological range of retinoids (Bucco et al., 1995; 
Horton and Maden, 1995; review Maden, 2000;  review Ross et al., 2000;  review 
Clagett-Dame and DeLuca, 2002).   
β-carotene found in plants and retinyl esters found in animal products provide the 
primary dietary sources of retinol (Napoli, 1996; Wolf, 1996), and intestinal enzymes 
convert these precursors to retinal and retinol, respectively.  Retinol-binding protein 
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(RBP) assists in the systemic and intercellular transport of retinol (Blomhoff et al., 1990; 
Gudas et al., 1994; Wolf, 1996).  Cellular retinol binding proteins (CRBPs) and cellular 
retinoic acid binding proteins (CRABPs) modulate intracellular vitamin A homeostasis 
by sequestering and stabilizing retinol, only allowing only certain enzymes access to the 
molecule (Mangelsdorf et al., 1994; Ghyselinck et al., 1999; review Noy, 2000).  Several 
of these cellular retinoid binding proteins have been characterized in reproductive tissues 
(Gao et al., 1991; Liu et al., 1993; Mackenzie et al., 1997; Zheng et al., 1999; Eberhardt 
et al., 1999a; Brown et al., 2003).  In addition, these proteins along with retinoid-
associated enzymes and nuclear retinoic acid receptors (RARs and RXRs) have been 
localized during preimplantation embryonic development (Horton and Maden, 1995; 
Rühl et al., 2001; Mohan et al., 2002); thus, suggesting the early embryo can access and 
utilize retinol and/or its metabolites.    
The lack of dietary vitamin A has been associated with reproductive deficiencies 
such as decreased sizes of ovaries and testes (Ganguly, 1989), decreased steroid 
biosynthesis (Juneja et al., 1966), increased fetal demise (McCollum, 1964), and most 
recently abnormal placental apoptosis (Antipatis et al., 2002).  The positive effects of 
vitamin A on reproduction have been reported for several species.  For instance, litter-
bearing animals receiving either β-carotene or retinol during superovulation displayed an 
increase in the number of live births (Besenfelder et al., 1993; Coffey and Britt, 1993), 
and an increase in ovulation rate as well as increased recovery of embryos (Elmarimi et 
al., 1990).  In addition, retinol injections to gilts fed a high-energy diet increased the 
follicular fluid concentration of progesterone and insulin-like growth factor (IGF-1), both 
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of which are necessary for normal embryonic development and early pregnancy (Whaley 
et al., 2000).          
Data collected in our lab demonstrated that 1-4 cell and morula stage embryos, 
collected from the oviduct and uterus, respectively, of all-trans-retinol treated, 
superovulated ewes exhibited improved capacity to develop to the blastocyst and hatched 
blastocyst stage during in vitro culture (IVC).  In addition, these experiments revealed 
that most embryos from ewes not treated with retinol (60%) did not progress beyond the 
eight-cell stage in vitro (Eberhardt et al., 1999b).  Despite the numerous in vivo studies 
that have demonstrated the importance of retinoids and its derivatives during embryonic 
and fetal development (review Hofmann and Eichele, 1994; Neiderreither et al., 1999; 
Eberhardt et al., 1999b;  review Ross et al., 2000; Whaley et al., 2000), few have 
investigated the effects of in vitro retinoid supplementation on preimplantation embryo 
development (Huang et al., 2001; Duque et al., 2002; Hidalgo et al., 2003; Huang et al., 
2003).  Furthermore, in vivo studies do not allow us to determine if the effect of retinol is 
on the oocyte, embryo, follicle, reproductive tract and/or its secretions; therefore, in vitro 
experiments were designed to help clarify the effects of retinol.    
In the present study, we have investigated the effects of in vitro retinol 
administration to maturing bovine oocytes and early embryos.  Results suggest 
concentration dependent, positive and negative effects on embryonic development. 
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MATERIALS AND METHODS 
 
 
Reagents and Media 
All chemicals were purchased from Sigma Chemical Company, St. Louis, MO 
unless otherwise noted.  Bovine oocyte collection medium (OCM) was composed of 
modified M199, 4.2 mM NaHCO3, 12 mM HEPES, and supplemented with 2mM 
glutamine, 2% fetal bovine serum - FBS (BioWhittaker, Baltimore, MD), and 
penicillin/streptomycin (Specialty Media, Phillipsburg, NJ).  Oocyte maturation medium 
(OMM) consisted of bicarbonate buffered TCM-199 supplemented with 50 µg/mL of 
gentamycin, purchased from Specialty Media, 5 µg/mL of FSH purchased from 
Vetrepharm Inc. (Ontario, Canada), 0.3 µg/mL of lutenizing hormone (LH), generously 
provided by the USDA, Beltsville, MD, 10% FBS, 0.2 µM sodium pyruvate and 2 mM 
glutamine.  The in vitro fertilization (IVF) medium was composed of TALP 
supplemented with 6 mg/mL of BSA-FAF, 0.2 mM sodium pyruvate, 1.75 U/ml of 
heparin, and 50 µg/mL of penicillin (10,000 U)/streptomycin (10 mg) (pen/strep).  The 
medium used for in vitro culture (IVC) was a modified synthetic oviductal fluid (mSOF) 
(Tervit et al., 1972) supplemented with 3mg/mL of bovine serum albumin (BSA), 0.6 
mM sodium pyruvate, 2% (v/v) BME essential amino acids, 1% (v/v) MEM non-essential 
amino acids, and 100 µg/mL of penicillin and streptomycin.   
 All-trans retinol was dissolved in 100% ethanol, appropriate dilutions made, and 
aliquots were stored at -80°C until use.  Retinol was prepared fresh each month.  The 
concentration of ethanol during maturation or culture was less than 0.1%. 
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Collection and In Vitro Maturation (IVM) of Oocytes 
For studies on the effects of retinol treatment during oocyte maturation, ovaries 
from cattle were obtained from an abbatoir and pooled.  Cumulus oocyte complexes 
(COCs) were quickly harvested by slicing healthy follicles (2 –8 mm) with a sterile 
surgical blade, and collecting them in OCM.  Intact COCs with homogeneous ooplasm 
and two or more layers of cumulus cells were selected, washed, and approximately 50 
were transferred to 500 µl of pre-equilibrated OMM, and matured for 22-23 hours in a 
38.5°C incubator with an atmosphere of 5.5% CO2, and humidified air. 
For studies on the effect of retinol administration during embryo culture, selected 
COCs were purchased from BoMed Inc. (Madison, WI).  These COCs were shipped 
overnight in OMM, maintained at 38.5°C by a portable incubator, and arrived mature. 
 
In Vitro Fertilization (IVF) 
 Fertilization (Day 0) was performed by combining semen from two bulls of 
proven fertility.  Frozen/thawed bull semen were washed in a discontinuous Percoll 
gradient (45%/90%) by depositing semen on top of the Percoll layers and centrifuged for 
15 minutes at 960 g.  The pellet was removed and resuspended in Sperm-TALP and 
centrifuged for 8 minutes at 460 g.  After removal of the supernatant, the sperm sample 
was reconstituted in 500 µL of IVF-TALP for a final concentration of 1 x 106 
spermatozoa/mL.  To aid in capacitation, 25 µl of PHE (penicillamine, hypotaurine, 
epinephrine) was added to each well.  The plate was incubated for 22 hours at 38.5°C in 
an atmosphere of 5.5% CO2 and ambient air with saturated humidity.   
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In Vitro Culture (IVC) 
Approximately 18 hours after fertilization putative zygotes were denuded of 
cumulus cells by vortexing in 500 µl of HEPES-TALP for four minutes (Day 1).  HEPES 
was supplemented with 3 mg/mL of BSA, 0.2 mM sodium pyruvate, and 50 µg/mL of 
pen/strep.  Putative zygotes (approximately 25-30) were cultured in 500 µL of mSOF for 
eight days in a 38.5°C incubator in an atmosphere of 5.5% CO2, 7% O2, 88% N2 with 
saturated humidity.  The mSOF medium was changed every 48 hours.  Cleavage was 
assessed on Day 3 and blastocyst rate was calculated on Day 8. 
 
Blastocyst Cell Number 
To determine cell number, nuclei of Day 8 blastocysts were stained with 50 µg/ml 
of bisbenzamide (Hoechst 33258; Sigma) dissolved in HEPES-TALP.  Briefly, 50 µl of 
Hoechst was added to 10 mL of HEPES-TALP, and blastocysts were placed in 500 µl 
under a cover protected from light for 20 minutes, and viewed with a 100X objective 
under UV light.  The nuclei of each blastomere were counted with the assistance of the 
Metamorph Imaging Software (Universal Imaging Corp., PA). 
 
Treatments 
 In the first experiment maturation medium was supplemented with all-trans 
retinol (0, 1.0, 5.0, and 10.0 µM) and embryo development to the hatched blastocyst 
stage (Day 8) was recorded.  In the second experiment all-trans retinol was added only to 
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embryo culture medium (0, 1.0, 2.0, 5.0 and 10 µM) on days 1, 3, 5, and 7 and embryo 
development to the hatched blastocyst stage (Day 8) was recorded.   
 
Data Analysis 
 Data were checked for normality and analyzed using an incomplete block design, 
blocked on plate with mixed model ANOVA methods in SAS (2000), as well as 
randomized block design for the IVC experiments.  Differences were detected using 
Fisher’s protected least significant difference.  Contrasts were used to test if the average 
of retinol treatments differed from the control.  A probability of p<.05 was considered 
significant for all statistical tests. 
 
RESULTS 
 The first experiment assessed the effects of retinol addition during IVM and 
represented twenty-seven replicates.  The addition of 5µM retinol during IVM tended to 
improve (p=.07) embryonic development to the blastocyst stage, compared to controls 
(Table 3-1).  The control blastocyst rate was 21.9% compared to 26.1% in 5 µM retinol.  
Addition of 1µM retinol to the maturation medium did not appear to affect embryonic 
development compared to controls.  10µM retinol increased blastocyst development, 
although not significantly.  Cleavage rate, 8–16 cell, and cell number of blastocysts did 
not differ among the four treatments.   
 Further analysis (13 replicates) revealed (Table 3-2) that if development to the 
blastocyst stage of controls was below 20%, the 5µM retinol treatment dramatically 
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Table 3-1.  Effect of all-trans retinol addition to bovine oocyte maturation medium (mean ± S. E. M.) on embryo development.  
The number of blastocysts counted is represented by (n). 
 
 
Retinol 
concentration 
(µM) 
 
Putative 
zygote 
(n) 
 
Cleavage 
 
8 – 16 
cell/putative 
zygote 
 
Blastocyst/ putative 
zygote 
 
Blastocyst/ 
cleaved 
 
 
Nuclei 
number 
(n) 
 
       
0 1095 66.7 ± 2.7 46.1 ± 2.6 21.9 ± 1.9 32.8 ± 2.2 73.6 (78) 
 
1.0 464 65.5 ± 3.9 47.9 ± 3.6 20.4 ± 2.6 31.7 ± 3.1          91.5 (14) 
 
5.0 1069 68.3 ± 3.2 50.8 ± 3.0 26.1 ± 2.2 37.1 ± 2.5 79.6 (110) 
 
10.0 508 70.1 ± 3.9 46.3 ± 3.7 24.2 ± 2.7 33.8 ± 3.1 71.6 (15) 
 
(n) represents the total number of blastocysts counted. 
Values are listed as percentages. 
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Table 3-2.  Effect of all-trans retinol addition to bovine oocyte maturation medium on embryo development among replicate 
groups where less than 20% of control embryos reached the blastocyst stage (mean ± S. E. M.). 
 
 
Retinol 
concentration 
(µM) 
 
Putative 
zygote 
(n) 
 
Cleavage 
 
8 – 16 
cell/putative 
zygote 
 
Blastocyst/ putative 
zygote 
 
Blastocyst/ 
cleaved 
 
      
0 
 
516 62.7 ± 3.9 39.4 ± 3.2 14.4 ± 2.1b 23.7 ± 2.6b 
1.0 
 
185 60.0 ± 6.0 37.0 ± 5.1 15.9 ± 3.4ab 26.1 ± 4.2ab 
5.0 
 
530 65.9 ± 4.6 45.9 ± 3.9 23.7 ± 2.5a 34.6 ± 3.1a 
10.0 
 
183 63.3 ± 6.7 35.0 ± 5.7 17.6 ± 3.8ab 26.7 ± 4.6ab 
ab  Means in the same column with different supercripts are different (p<.05). 
Values are listed as percentages.
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improved (p<.02) embryo development (14.4 % vs. 23.7%).  When expressed as 
blastocyst/cleaved the 5µM retinol treatment (p<.02) also showed a significant 
improvement in blastocyst development.  Neither 1µM nor 10µM retinol treatment 
improved embryonic development when compared to those controls that did not achieve 
a 20% blastocyst rate.   
 The addition of retinol during IVC only (13 replicates) (Table 3-3), did not 
improve development to the blastocyst stage compared to controls, at any concentration 
tested.  In fact, a concentration-dependent inhibition of blastocyst development was 
observed with 5µM and 10µM retinol treatments compared to controls, 1 µM, and 2µM 
retinol treatments.  Conversely, the 5µM retinol treatment increased blastocyst nuclei 
number (p<.03) compared to controls.  Cleavage rates as well as development to the 8-
cell stage did not differ significantly among embryos treated with and without retinol 
during culture. 
 
DISCUSSION 
In vivo studies performed with laboratory animals (Elmarimi et al., 1990; 
Besenfelder et al., 1993) and large domestic animals (Coffey and Britt, 1993; Shaw et al., 
1995; Eberhardt et al., 1999b; Whaley et al., 2000) have demonstrated that retinol 
administration prior to ovulation positively impacts preimplantation embryonic 
development.  Previous work in our laboratory provided evidence that retinol 
administration to ewes, during superovulation, improved embryonic development in 
vitro, and may have been responsible for helping embryos progress beyond the 8-16 cell  
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Table 3-3.  Effects of all-trans retinol addition to the culture medium during embryo development only (mean ± S. E. M.).   
 
 
Retinol 
concentration 
(µM) 
 
Putative 
zygote 
(n) 
 
Cleavage 
 
8 – 16 
cell/putative 
zygote 
 
Blastocyst/ putative 
zygote 
 
Blastocyst/ 
cleaved 
 
 
Nuclei 
number 
(n) 
 
       
0 
 
567 86.1 ± 2.5 68.2 ± 2.5 26.5 ± 2.4ab 30.7 ± 2.6a 72.2 (47)b 
1.0 
 
312 84.7 ± 3.2 67.3 ± 3.3 27.1 ± 3.2ab 32.1 ± 3.5a 76.9 (48)ab 
2.0 
 
414 85.3 ± 2.9 69.1 ± 2.9 28.8 ± 2.8a 34.1 ± 3.1a 80.4 (21)ab 
5.0 
 
303 80.8 ± 3.2 63.9 ± 3.3 20.2 ± 3.2bc 25.4 ± 3.5ab 84.8 (39)a 
10.0 
 
388 81.2 ± 3.0 63.4 ± 3.1 13.5 ± 3.0c 16.2 ± 3.3b 78.3 (21)ab 
ab  Means in the same column with different supercripts are different (p<.05). 
(n) represents the total number of blastocysts counted. 
Values are listed as percentages. 
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stage (Eberhardt et al., 1999b), a critical time period when embryos typically block in 
vitro (Telford et al., 1990).  Since retinol was administered prior to ovulation, maturing 
oocytes within ovulatory follicles were considered likely targets of retinoid action.  
Therefore, over 3000 bovine oocytes were used to evaluate the effects of retinoid 
supplementation during IVM and IVC on embryonic development to the blastocyst stage. 
Maturation of bovine oocytes in the presence of 1µM and 10µM retinol did not 
increase nor decrease the blastocyst rate; however, 5µM retinol tended to improve 
blastocyst rate when compared to control oocytes (p=.07) (Table 3-1).  A more dramatic 
effect of the 5µM retinol treatment was observed if control embryos did not achieve a 
20% blastocyst rate.  In this case, 5µM retinol increased blastocyst development more 
than 10% (Table 3-2).  These results suggest that retinol may not be helping an oocyte 
already capable of progressing, but rather it is improving the viability of an otherwise 
incompetent oocyte.   
During growth, within the follicle, the oocyte accumulates RNA and proteins in 
order to complete nuclear and cytoplasmic maturation, progress through fertilization, its 
early cleavage stages, and the maternal to embryonic gene transition (review Brevini-
Gandolfi and Gandolfi, 2001).  It is possible that retinol may be impacting nuclear and/or 
cytoplasmic maturation in a way that is beneficial to the developing cumulus oocyte 
complex and/or embryo.  Vitamin A administration to gilts, fed a high-energy diet, 
increased the average developmental stage of oocytes, specifically decreasing the number 
arrested at germinal vesicle stage (Whaley et al., 2000).   
Recently, two experiments from the same laboratory demonstrated that 
pretreatment of bovine oocytes with 9-cis-retinoic acid, prior to IVM and resumption of 
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meiosis, improved blastocyst development (Duque et al., 2002) and pregnancy rates 
(Hidalgo et al., 2003).  Conclusions made from these data suggest that retinoic acid may 
impact oocyte cytoplasmic maturation, an important event, which must occur during 
maturation (Eppig et al., 1994; Combelles et al., 2002). 
Although vitamin A is essential for normal embryonic development, both excess 
and deficiency result in abnormal development (Moore, 1957; Wellik and DeLuca, 1995; 
Huang et al., 2001; Antipatis et al., 2002; Niederreither et al., 2002; Huang et al., 2003).  
Results from the present study illustrate the requirement for tight regulation of retinol 
concentrations and indicate that the developing oocyte, within its cumulus investment, 
and the early embryo respond differently to varying concentrations of retinol. 
In this study, 5µM retinol treatment applied during IVM improved embryonic 
development, and 10µM retinol did not reveal any negative effects.  In contrast, 10µM 
supplementation during IVC was detrimental to embryonic development (Table3-3).  
Furthermore, 5µM retinol treatment during IVC was detrimental compared to 2µM 
retinol (Table 3-3).  Cumulus cells play a vital role in nuclear and cytoplasmic oocyte 
maturation, metabolism and conversion of nutrients, and they relay important information 
(i.e. hormonal and growth factor signaling) between the oocyte and its surrounding 
follicle (Downs et al., 1997; Tanghe et al., 2002; Sutton et al., 2003).  In this study, the 
cumulus cells may have provided a layer of protection to the maturing oocyte, whereas 
the denuded embryo was more susceptible to higher concentrations of retinol (10µM and 
5µM) in the culture medium.   
Even though 5µM retinol administered during IVC decreased blastocyst 
development compared to controls, it improved blastocyst cell number (Table 3-3).  A 
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recent study demonstrated that 9-cis-retinoic acid influences the ratio of the inner cell 
mass and trophectoderm cells in the blastocyst stage embryo (Hidalgo et al., 2003).  
Furthermore, several studies have shown that retinoids, retinoic acid in particular, are 
anti-apoptotic depending on the tissue and concentration (Moreno-Manzano et al., 1999; 
Zhou et al., 1999; Konta et al., 2001).  Retinoic acid can also activate mitosis via the 
mitogen activated protein kinase pathways (MAPK) (Koshimizu et al., 1995; Morita and 
Tilly, 1999).  Apoptosis during early development is a necessary event in order for the 
embryo to differentiate properly (Hardy, 1999; Matwee et al., 2000; Van Soom et al., 
2002).  Although retinol increased the cell number of the blastocyst stage embryo this 
may not be beneficial, (Van Soom et al., 2002) especially if it is influencing cells 
normally programmed to undergo apoptosis.   
The favorable effects of retinol on in vitro bovine blastocyst development may be 
modulated by growth factors.  Since embryo development is characterized by rapid 
cellular proliferation and cellular differentiation, growth factors are essential for this 
process (Bavister, 1995; Kane et al., 1997; Teruel et al., 2000).  Evidence exists that 
retinoids affect certain growth factor expression levels.  For example, midkine, a member 
of the heparin-binding growth/differentiation family is induced by retinoic acid, and it 
has been found to improve bovine oocyte and embryo developmental competence (Ikeda 
et al., 2000; Ikeda et al., 2000).  In addition, retinoic acid was found to regulate epidermal 
growth factor receptor expression (EGFR), (Roulier et al., 1994) and transforming growth 
factor (TGF-ß) and insulin-like growth factor binding protein (IGFBP3) expression (Han 
et al., 1997). 
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Our results strongly suggest that 5µM retinol addition may modify the 
environment in which the oocyte is maturing; thus, allowing “incompetent” oocytes to be 
fertilized and develop to the blastocyst stage.  One hypothesis is that this retinol-induced 
alteration may decrease oxidative stress.  According to some, the leading cause of early 
embryonic loss during IVC may be oxidative stress, generated by reactive oxygen species 
(ROS) (Takahashi et al., 2000; Guérin et al., 2001).  The deleterious effects of ROS on 
preimplantation embryos include protein, lipid, and nucleic acid damage, mitochondrial 
alterations, cell cycle block, ATP depletion, and excessive apoptosis (Salas-Vidal et al., 
1998; Guérin et al., 2001).  Several reports have demonstrated positive effects of 
antioxidants such as Mn-SOD and/or catalase (Liu and Foote, 1995; Dinara et al., 2001; 
Orsi and Leese, 2001), vitamins E and C (Olson and Seidel Jr, 2000; Wang et al., 2002), 
and glutathione (Luvoni et al., 1996; de Matos and Furnus, 2000; de Matos et al., 2002) 
during IVM and IVC. 
Certain studies have highlighted the importance of culturing embryos in a low 
oxygen atmosphere (5-7%) to increase blastocyst development (Pabon et al., 1989; 
Voelkel et al., 1992; Liu and Foote, 1995; Takahashi et al., 2002).  Since oocyte 
maturation in vitro occurs in a 20% oxygen atmosphere, but embryo culture takes place 
in a lower oxygen atmosphere (7%), this may partially explain why retinol has a positive 
effect during maturation but not during embryo culture.  Furthermore, it may help 
elucidate why 5µM and 10µM retinol appear detrimental to the early embryo but not the 
oocyte.  Studies conducted during oocyte and embryonic development have demonstrated 
negative effects of retinoic acid (Huang et al., 2001; Huang et al., 2003). 
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The positive effects of retinol on early embryonic development have been 
observed both in vivo when administered to ewes prior to ovulation (Eberhardt et al., 
1999b), and in the present study when provided during bovine in vitro maturation (Tables 
3-1 and 3-2).  Retinol may be imparting developmental competence to an otherwise 
incompetent oocyte through several mechanisms such as modulating growth factors, 
affecting developmental gene expression, or by an antioxidant mechanism that decreases 
free radical production in the culture system.  In addition, with an increase in blastocyst 
cell number (Table 3-3) retinol may be acting via retinoic acid to decrease programmed 
cell death in the embryo.  Future studies will be aimed at dissecting the pathways that 
retinol and its metabolites utilize to improve early embryonic development. 
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CHAPTER 4 
 
 
The Effects of Retinol on In Vitro Matured Bovine Oocyte 
Glutathione Content and its Combinatorial Role with 
Cysteamine During In Vitro Bovine Embryonic Development 
 
 
ABSTRACT 
 
 Retinoids serve important roles in many diverse biological functions such as cell 
growth, morphogenesis, differentiation, and reproduction.  Previous studies demonstrated 
that retinol administration to ewes, followed by natural service, resulted in embryos with 
improved competence to develop in vitro.  Glutathione is an important compound found 
in oocytes and embryos.  The present study evaluated the in vitro effects of retinol or 
cysteamine addition to oocyte maturation medium on the glutathione content of mature 
bovine oocytes.  In addition, the combinatorial effects of retinol and cysteamine addition 
to the maturation medium (IVM) and/or embryo culture (IVC) were assessed.  Bovine 
oocytes were matured in the presence or absence of retinol, denuded, and the glutathione 
content measured.  Results did not show a difference between oocytes matured in the 
presence or absence of retinol, respectively (4.02 vs 3.98 pmol/oocyte); however, 100µM 
cysteamine addition during IVM doubled the glutathione content (8.37 pmol/oocyte). In 
the second experiment, bovine oocytes were matured in the presence or absence of retinol 
and/or cysteamine.  After IVM the oocytes were fertilized, denuded (Day 1), and cultured 
in a modified synthetic oviductal fluid (mSOF) in a humidified atmosphere at 38.5°C, 
5.5% CO2, 7% O2.  Combinations of retinol and/or cysteamine were added during IVC on 
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Day 1.  Cleavage rates were similar in all treatments except when retinol and cysteamine 
were both added during IVM and IVC, which displayed a decrease in cleavage.  In 
contrast, this same treatment combination had the highest blastocyst development rate 
(22.7%), and the highest blastocyst/cleaved rate (38.3%), which was significantly 
different from the controls.  Control blastocyst rates were 14.7% as were treatments that 
included retinol and cysteamine during IVC (14%), or only retinol during IVM 14.1%).   
 
INTRODUCTION 
 
 
In vitro culture conditions impose many different stressors on preimplantation 
embryos such as increased metabolic and osmotic stress, altered pH levels (Lane, 2001), 
and oxidative stress (review Guérin et al., 2001).  Oxidative stress defined as “a 
disturbance in the prooxidant/antioxidant system” (Sies, 1995), is perhaps the leading 
cause of early embryonic loss, particularly during in vitro culture (review Takahashi et 
al., 2000; Guérin et al., 2001).  Recently, investigators discovered that reducing levels of 
free radicals during in vitro culture improved embryonic development (Iwata et al., 1998;  
review Guérin et al., 2001; review Lane, 2001; de Matos et al., 2002;  review Dröge, 
2002).   
Reactive oxygen species (ROS) are generated during normal cellular processes 
resulting in the production of superoxide anion, hydrogen peroxide, and hydroxyl radicals 
(Gutteridge, 1995;  review Dröge, 2002).  Endogenous sources of ROS during embryo 
development include oxidative phosphorylation, NADPH oxidase (produces superoxide 
anion and hydrogen peroxide), and xanthine oxidase (degrades purine nucleotides).  
Exogenous sources that may result in production of ROS include high oxygen 
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concentration, metallic cations, visible light, and sperm (Salas-Vidal et al., 1998; review 
Guérin et al., 2001;  review Dröge, 2002).   Deleterious effects of ROS on 
preimplantation embryos include protein, lipid, and nucleic acid damage, mitochondrial 
alterations, cell cycle block, ATP depletion, and excessive apoptosis (Salas-Vidal et al., 
1998; Guérin et al., 2001).  Furthermore, increased oxygen radicals in mouse embryos 
cultured in vitro are implicated in developmental blockage that is common during in vitro 
culture (Goto et al., 1993).  
Glutathione (GSH) is the major non-protein sulphydryl compound found in 
mammalian cells responsible for strong basal ROS scavenging activity (Dröge, 2002), 
and several reports highlight the importance of maintaining adequate glutathione levels in 
both oocytes and early embryos.  For example, mouse embryos chemically depleted of 
GSH exhibited retarded development, which was reversed with exogenous GSH 
(Gardiner et al., 1998).  Buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, 
has been shown to compromise blastocyst development of 6-8 cell bovine embryos 
(Takahashi et al., 1993).   Further studies confirmed the beneficial effects of maintaining 
GSH levels during IVM (bovine, mouse, pig) on subsequent embryo development 
(Luvoni et al., 1996; Furnus et al., 1998; Knappen et al., 1999; de Matos and Furnus, 
2000; Shi et al., 2000; Brad et al., 2003).   
GSH is a tripeptide thiol composed of gluatmic acid, cysteine, and glycine.  It is 
synthesized in the γ-glutamyl pathway, and cysteine availability is a rate-limiting step 
(Deplancke and Gaskins, 2002).  Outside the cell, cysteine is unstable and rapidly 
oxidized to cystine, a cysteine dimer, in culture medium (Takahashi et al., 1993; 
Takahashi et al., 2002).  Some cell types, including bovine embryos, exhibit low cystine 
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transport activity, which may negatively impact GSH synthesis (Takahashi et al., 1993).  
Thiol compounds, such as ß-mercaptoethanol (ß-ME) and cysteamine, reduce cystine to 
cysteine and promote uptake of both compounds.  Addition of ß-ME or cysteamine to 
culture medium of maturing oocytes, or embryos has resulted in increased glutathione 
content and improved embryonic development of several species (Gasparrini et al., 2000; 
de Matos et al., 2002; Takahashi et al., 2002; de Matos et al., 2003). 
Retinoids play important roles in bone formation, pattern development, and 
overall reproductive success (Gudas et al., 1994; Hofmann and Eichele, 1994; Napoli, 
1996; Wolf, 1996).  Ultimately, the metabolites of vitamin A (retinol), all-trans-retinoic 
acid and 9-cis-retinoic acid, together with their receptors (RARs and RXRs), regulate 
retinoid action at the level of gene expression (Wendling et al., 1999; Konta et al., 2001;  
review Ross et al., 2001).  Vitamin A deficiencies in animals (Moore, 1957; McCollum, 
1964; Ross et al., 2000), as well as supplementation with retinol, have clearly defined the 
importance of this vitamin during early embryonic and fetal development (Wellik and 
DeLuca, 1995; Besenfelder et al., 1996; Eberhardt et al., 1999b; Whaley et al., 2000).  
Under certain conditions vitamin A and carotenoids participate in a biological antioxidant 
network, and have been implicated as important regulators of redox signaling pathways 
(Imam et al., 2001).  Specifically, carotenoids quench singlet oxygen molecules as well 
as interact with other antioxidant compounds (Olson, 1993).   
Studies have demonstrated the beneficial effects of in vivo retinoid 
supplementation to litter-bearing species (Elmarimi et al., 1990; Besenfelder et al., 1996), 
as well as during in vitro preimplantation embryonic development (Hidalgo et al., 2002; 
Livingston et al., 2002; Hidalgo et al., 2003).  In other cell lines retinoids, particularly 
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retinoic acid, protected cells from oxidative stress-induced apoptosis (Ahlemeyer and 
Krieglstein, 1998; Ahlemeyer et al., 2001), and inhibited glutathione depletion by 
preserving the antioxidant, superoxide dismutase (SOD) levels (Ahlemeyer and 
Krieglstein, 2000).  Furthermore, another report provided evidence that retinoids 
modulate glutathione content in certain cell lines (Texeira et al., 1996).  Retinoids 
suppress apoptosis in a number of cell lines by different mechanisms.  For example, a 
study conducted in mesangial cells exposed to hydrogen peroxide (H2O2) demonstrated 
the anti-apoptotic effects of RA by inhibiting c-Jun NH2-terminal kinase  (JNK) and 
activating protein (AP-1) (Moreno-Manzano et al., 1999).  A retinoic acid response 
element (RARE) was also found in the promoter region of glutathione transferase pi 
(GSTp) (Lo and Ali-Osman, 1997), an important enzyme that participates in 
detoxification of foreign compounds.  Additionally, GSTp has also been found to regulate 
JNK signaling (Adler et al., 1999). 
  From these studies we hypothesized that retinol may aid in the conversion of 
cystine to cysteine or promote its uptake; thereby, increasing glutathione levels and 
improving embryonic development.  In the first experiment we measured the glutathione 
content of in vitro matured bovine oocytes after retinol or cysteamine supplementation 
during IVM.  Secondly, we evaluated the combinatorial effects of retinol and cysteamine 
supplementation during IVM and/or IVC on bovine preimplantation embryonic 
development. 
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MATERIALS AND METHODS 
Reagents and Media 
All chemicals were purchased from Sigma Chemical Company, St. Louis, MO 
unless otherwise noted.  Bovine oocyte collection medium (OCM) was composed of 
modified M199, 4.2 mM NaHCO3, 12 mM HEPES, and supplemented with 2mM 
glutamine, 2% fetal bovine serum - FBS (BioWhittaker, Baltimore, MD), and 
penicillin/streptomycin – pen/strep (Specialty Media, Phillipsburg, NJ).  Oocyte 
maturation medium (OMM) consisted of bicarbonate buffered TCM-199 supplemented 
with 50 µg/mL of gentamycin, purchased from Specialty Media, 5 µg/mL of FSH 
purchased from Vetrepharm Inc. (Ontario, Canada), 0.3 µg/mL of lutenizing hormone 
(LH) (generously provided by the USDA, Beltsville, MD), 10% FBS, 0.2 µM sodium 
pyruvate and 2 mM glutamine.  The in vitro fertilization (IVF) medium was composed of 
TALP supplemented with 6 mg/mL of BSA-FAF, 0.2 mM sodium pyruvate, 1.75 U/ml of 
heparin, and 50 µg/mL of penicillin (10,000 U)/streptomycin (10mg) (pen/strep).  The 
medium used for in vitro culture (IVC) was a modified synthetic oviductal fluid (mSOF) 
(Tervit et al., 1972) supplemented with 3mg/mL of BSA, 0.6 mM sodium pyruvate, 2% 
(v/v) BME essential amino acids, 1% (v/v) MEM non-essential amino acids, and 100 
µg/mL of penicillin and streptomycin.   
 All-trans retinol was dissolved in dimethylsulfoxide (DMSO), cysteamine was 
dissolved in water, and both were stored at -20°C until use.  Retinol and cysteamine were 
prepared fresh each week.  The concentration of DMSO during maturation or embryo 
culture did not exceed 0.1%.   
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Collection and In Vitro Maturation (IVM) of Oocytes 
For studies on the effects of retinol and cysteamine treatment during oocyte 
maturation, ovaries from cattle were obtained from an abbatoir and pooled.  Cumulus 
oocyte complexes (COCs) were quickly harvested by slicing healthy follicles (2–8 mm) 
with a sterile surgical blade and collecting them in OCM.  Intact COCs with 
homogeneous ooplasm and two or more layers of cumulus cells were selected, washed, 
and approximately 50 were transferred to 500 µl of pre-equilibrated OMM, and matured 
for 22-23 hours in a 38.5°C incubator with an atmosphere of 5.5% CO2, ambient air, and 
saturated humidity. 
 
In Vitro Fertilization (IVF) 
 Fertilization (Day 0) was performed by combining semen from two bulls of 
proven fertility.  Frozen/thawed bull semen were washed in a discontinuous Percoll 
gradient (45%/90%) by depositing semen on top of the Percoll layers and centrifuged for 
15 minutes at 960g.  The pellet was removed and resuspended in Sperm-TALP and 
centrifuged for 8 minutes at 460g.  After removal of the supernatant, the sperm sample 
was reconstituted in 500 µL of IVF-TALP for a final concentration of 1 x 106 
spermatozoa/mL.  To aid in capacitation, 25 µl of PHE (penicillamine, hypotaurine, 
epinephrine) was added to each well.  The plate was incubated for 22 hours at 38.5°C in 
an atmosphere of 5.5% CO2 and ambient air with saturated humidity.   
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In Vitro Culture (IVC) 
Approximately 18 hours after fertilization putative zygotes were denuded of 
cumulus cells by vortexing in 500 µl of HEPES-TALP for approximately four minutes 
(Day 1).  HEPES was supplemented with 3mg/mL of BSA, 0.2mM sodium pyruvate, and 
50µg/mL of pen/strep.  Putative zygotes (approximately 25-30) were cultured in 500 µL 
of mSOF for eight days in a 38.5°C incubator in an atmosphere of 5.5% CO2, 7% O2, 
88% N2 with saturated humidity.  The mSOF medium was changed on Days 1, 3, and 5.  
Cleavage was assessed on Day 3 and blastocyst rate was calculated on Day 8. 
 
Experiment 1:  Assay of Glutathione Content 
The glutathione (GSH) content of in vitro, matured bovine oocytes was measured 
to assess the effects of retinol and cysteamine.  Briefly, cumulus oocyte complexes were 
matured in the presence or absence of 5µM all-trans-retinol or 100µM cysteamine.  
Approximately 22-24 hours after IVM, oocytes were stripped of cumulus cells by 
vortexing in 500 µl of HEPES-TALP supplemented with hyaluronidase (50 µg/ml) for 
approximately four minutes.  The oocytes (30) were washed three times in stock buffer 
(0.2 M sodium phosphate-0.001 M sodium EDTA, pH 7.2), and transferred to a 
microcentrifuge tube in 5µl.  Phosphoric acid (1.25M, 5µl) was added to achieve a final 
concentration of 0.625 M H3PO4.  The oocytes were immediately frozen (-20°C).   
The GSH assay described is a modification based on the recycling assay of the 
enzyme 5,5-dithiobis-(2-nitrobenzoic acid)-glutathione reductase (DTNB-GSSG), 
described by Tietze (Tietze, 1969) and later modified by Calvin (Calvin et al., 1986) and 
Anderson (Anderson, 1985).  The method explained here is most similar to that of 
 75
Anderson (Anderson, 1985).  The following chemicals were purchased from Sigma 
Chemical Co. (St. Louis, MO):  5,5-dithiobis-(2-nitrobenzoic acid - DTNB), phosphoric 
acid (H3PO4), sodium phosphate hydrated (NaH2PO4H2O), sodium phosphate 
(Na2HPO4), ethylenediaminetetraacetic acid (EDTA), reduced glutathione, and β-
nicotinamide adenine dinucleotide phosphate reduced tetrasodium salt (NADPH), and 
glutathione reductase. 
Samples were thawed, centrifuged, and microscopically evaluated to ensure 
complete lysis of the oocytes.  To each sample, 700µl of the NADPH solution (1mL of 
stock buffer added to 1mg bottle of NADPH), 100µl of 6mM DTNB, 180µl of distilled 
water, and 10µl of glutathione reductase (266U/ml) were quickly added to a disposable 
cuvette, placed in a Beckman single-beam DU-640 (Irvine, CA) spectrophotometer, and 
the increase in absorbance at 412nm was measured every 30 seconds for 2 minutes.  Each 
blank included 5µl of water and 5µl of phosphoric acid, and did not show detectable 
amounts of GSH-GSSG.  Four glutathione (GSH) standards were made fresh (1nmol, 
0.5nmol, 0.25nmol, and 0.05nmol), in order to calculate the total GSH content of oocytes 
based on a standard curve (Tietze, 1969; Anderson, 1985; Calvin et al., 1986).   
 
Experiment 2:  Combinatorial Effect of Retinol and Cysteamine 
 Different combinations of retinol and/or cysteamine were chosen to evaluate and 
clarify the effect of retinol and cysteamine on in vitro blastocyst development.  
Treatments were added during IVM (Day –1), and after the putative zygotes were 
denuded (Day 1) during IVC.  The mSOF media was changed on Days 1, 3, and 5.  
Observations from preliminary experiments showed that treatment addition after Day 1 
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negatively impacted embryonic development; therefore, treatment was only added on 
Day 1.  Ten experimental groups were designed.  In the first experimental group, only 
maturation medium and culture medium were used.  In those experimental groups that 
contained retinol a diluent control was employed, which consisted of DMSO dissolved in 
either OMM of mSOF. 
1.) 0µM retinol and cysteamine and 0µM retinol or cysteamine during IVM and IVC, 
respectively (-/-). 
2.) 0µM cysteamine or retinol and 50µM cysteamine during IVM and IVC, 
respectively (-/C). 
3.) 0µM cysteamine or retinol and 2.5µM retinol during IVM and IVC, respectively 
(-/R). 
4.) 0µM cysteamine or retinol and 2.5µM retinol and 50µM cysteamine during IVM 
and IVC, respectively (-/R+C). 
5.) 100µM cysteamine and 0µM retinol and cysteamine during IVM and IVC, 
respectively (C/-). 
6.) 100µM cysteamine and 50µM cysteamine during IVM and IVC, respectively 
(C/C). 
7.) 2.5µM retinol and 0µM retinol and cysteamine during IVM and IVC, respectively 
(R/). 
8.) 2.5µM retinol and 2.5µM retinol during IVM and IVC, respectively (R/R). 
9.) 2.5µM retinol and 100µM cysteamine and 0µM retinol and cysteamine during 
IVM and IVC, respectively (R+C/-). 
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10.) 2.5µM retinol and 100µM cysteamine and 2.5µM retinol and 50µM cysteamine 
      during IVM and IVC, respectively (R+C/R+C). 
 
Data Analysis 
 Data were checked for normality and analyzed using a randomized block design 
with mixed model ANOVA methods in SAS (2000).  Differences were detected using 
Fisher’s protected least significant difference.  Contrasts were used to test if the average 
of the treatments differed from the control.  A probability of p<.05 was considered 
significant for all statistical tests. 
 
RESULTS  
 Intracellular glutathione content of more than 600 bovine oocytes was measured 
to evaluate the effects of retinol or cysteamine addition during IVM.  Results revealed 
that the GSH content of bovine oocytes matured in the presence of 5µM retinol was 
similar to control oocytes (4.02 vs 3.98 pmol/oocyte – Figure 4-1).  However, glutathione 
content of oocytes that were matured in the presence of 100µM cysteamine was more 
than double than that of controls (8.37 pmol/oocyte; p=0.06). 
More than 1200 oocytes were used in five independent replicates to evaluate the 
effects of retinol and/or cysteamine on bovine embryonic development.  All treatment 
combinations had similar cleavage rates except for R/- and R+C/R+C, which exhibited 
significantly lower cleavage (Table 4-1).  Development to the 8-16 cell stage did not  
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Figure 4-1.  Glutathione levels of in vitro bovine oocytes matured in the presence 
of retinol, cysteamine, or maturation medium only. 
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Table 4-1.  Effect of all-trans retinol (R) and cysteamine (C) during bovine IVM and IVC (mean ± S. E. M.)   
 
Treatment 
IVM / IVC 
Putative 
zygote 
 (n) 
Cleavage 8 – 16 cell/putative zygote Blastocyst/ putative zygote  Blastocyst/ 
cleaved  
 
      
 - / - 
 
118 72.6 ± 5.3a 45.2 ± 5.9abc 14.7 ± 4.1ab 21.2 ± 4.9b 
- / C 
 
117 74.3 ± 5.3ab 50.7 ± 5.9abc 17.8 ± 4.1ab 24.1 ± 4.9b 
- / R 
 
128 73.6 ± 5.3ab 57.5 ± 5.9a 20.8 ± 4.1ab 27.0 ± 4.9ab 
     - / R+C 
 
125 72.9 ± 5.3abc 57.1 ± 5.9a 14.0 ± 4.1ab 17.6 ± 4.9b 
      C / - 
 
121 76.4 ± 5.3a 56.2 ± 5.9ab 19.9 ± 4.1ab 25.7 ± 4.9ab 
C / C 
 
117 76.5 ± 5.3a 55.3 ± 5.9ab 19.5 ± 4.1ab 25.9 ± 4.9ab 
      R / - 
 
118 60.0 ± 5.3bc 39.3 ± 5.9bc 14.1 ± 4.1ab 23.4 ± 4.9b 
R / R 
 
118 68.9 ± 5.3abc 48.3 ± 5.9abc 10.9 ± 4.1b 15.2 ± 4.9b 
R+C / - 
 
125  69.8 ± 5.9abc 37.4 ± 6.7bc 19.2 ± 4.6ab 26.7 ± 5.5ab 
R+C / R+C 
 
152 58.2 ± 5.3c 37.4 ± 5.9c 22.7 + 4.1a 38.3 ± 4.9a 
 
abc Means in the same column with different supercripts are different (p<.05). 
Values are listed as percentages. 
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exhibit significant differences when compared to controls, but was numerically higher 
when retinol alone (-/R) was added during IVC or retinol with cysteamine (-/R+C).   
Similar development to the 8-16 cell stage was observed if cysteamine was present 
during IVC (-/C) or IVMC (C/C).  Retinol and cysteamine addition during IVM (R+C/ -) 
or during IVMC (R+C/R+C), reduced 8-16 cell development; however, the treatment 
combination of R+C/R+C exhibited the highest blastocyst development (22.7%).   
 Retinol and cysteamine addition (R+C/-) during IVM had a blastocyst rate of 
19.2%, which was comparable to cysteamine treatment alone during maturation (C/-), 
retinol treatment alone during IVC (-/R), and cysteamine treatment during maturation and 
culture (C/C).  Control blastocyst rate (-/-) and retinol treatment alone during IVM (R/-) 
had similar values (14.7 and 14.0, respectively).  Retinol addition during IVMC (R/R) 
had the lowest blastocyst rate (10.9%).  This was significantly lower than the R+C/R+C 
treatment combination (p<.05).   
Retinol and cysteamine together during IVM and IVC (R+C/R+C) showed a 
higher blastocyst/cleaved rate than controls (-/-), cysteamine alone during IVC (-/C), 
retinol alone during IVM (R/-), retinol treatment during IVMC (R/R), and retinol and 
cysteamine during IVC (-/R+C). 
 
DISCUSSION 
Recent studies by our laboratory (Eberhardt et al., 1999b; Livingston et al., 2002) 
and others (Whaley et al., 2000; Duque et al., 2002; Hidalgo et al., 2002) have 
demonstrated that retinoid treatment of oocytes and embryos positively impacts in vitro 
development.  In other cell systems, retinoic acid treatment decreased apoptosis through 
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participation in cellular defense mechanisms against oxidative stress.  For example, 
retinoic acid, protected certain cell lines from oxidative stress-induced apoptosis 
(Ahlemeyer and Krieglstein, 1998; Ahlemeyer et al., 2001), and inhibited glutathione 
depletion by preserving the antioxidant, SOD, levels (Ahlemeyer and Krieglstein, 2000).  
Texiera and colleagues provided evidence that retinoids modulate glutathione content in 
chondrocytes (Texeira et al., 1996).  Furthermore, a study conducted in mesangial cells 
exposed to hydrogen peroxide (H2O2), demonstrated anti-apoptotic effects of RA by 
inhibiting c-Jun NH2-terminal kinase (JNK) and activating protein (AP-1) (Moreno-
Manzano et al., 1999).  Based on this information, it was hypothesized that retinol may 
affect glutathione concentrations in maturing oocytes.   
In the first experiment, retinol supplementation (5µM) during IVM of bovine 
oocytes did not increase glutathione levels (Figure 4-1).  In contrast, cysteamine (100µM) 
treatment doubled the glutathione content.  Our control values are similar to other reports 
(de Matos et al., 1995; de Matos and Furnus, 2000; Hashimoto et al., 2000).  The failure 
of retinol to influence glutathione concentrations in maturing oocytes may have resulted 
from an inability of the oocyte to take up and utilize cysteine.  Outside the cell, cysteine 
is readily oxidized and converted to cystine, forming a dimer, which is difficult for the 
oocyte or embryo to utilize (de Matos et al., 1995; Takahashi et al., 2002).  Additions of 
thiol compounds such as beta-mercaptoethanol (β-ME) and cysteamine have been 
employed to increase cysteine availability, increase glutathione synthesis, and improve 
embryo development (de Matos et al., 1995; de Matos et al., 2002; Takahashi et al., 2002; 
de Matos et al., 2003).  It was hypothesized that dual treatment with cysteamine and 
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retinol may promote cysteine uptake, and improve utilization and redox regulation in 
embryos; resulting in improved blastocyst development. 
Retinol addition alone during IVM (R/-) significantly reduced cleavage (p<.05), 
but displayed similar blastocyst rates as controls (Table4-1).  This result is contradictory 
to an earlier study (Livingston et al., 2002), which showed that retinol addition (5µM) 
during IVM tended to improve blastocyst development.  The disagreement between the 
two studies may reflect concentration dependent effects of retinoids (Bagavandoss and 
Midgley, 1988).  High performance liquid chromatography (HPLC) analysis revealed an 
82% recovery of retinol (data not shown) after 48 hours in culture, suggesting that it is 
relatively stable; yet, breakdown products may exist and account for some of the 
observed discrepancies.  
Retinol supplementation during IVM and IVC (R/R) did not adversely affect 
cleavage, but did diminish blastocyst development (Table 4-1).  The concentration 
dependent effects of retinol may partially explain this result, because in our previous 
study higher concentrations of retinol (10µM) during IVC were detrimental to embryonic 
development (Livingston et al., 2002).  In certain cell lines retinoids influence the levels 
of manganese superoxide dismutase (Mn-SOD) (Ahlemeyer et al., 2001); thus, in the 
present study retinol may have increased SOD levels.  Dinara and colleagues reported 
that higher levels of SOD were harmful to oocytes because they increased H2O2 
production, which can ultimately result in an increase in OH• radical formation, leading 
to significant cellular damage (Dinara et al., 2001). 
Results from Experiment 2 also indicate that cysteamine supplementation during 
IVM or IVC only, or during both (C/C) did not significantly improve embryonic 
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development, although a numerical increase was observed (Table 4-1).  The 
concentration of cysteamine in our study was similar to de Matos and colleagues (de 
Matos et al., 2002); however, other studies have demonstrated that lower as well as 
higher concentrations of thiol compounds improve embryonic development (Takahashi et 
al., 1993; de Matos and Furnus, 2000), respectively.   
Retinol and cysteamine addition to IVM alone (R+C/-) or only during IVC  
(-/R+C) did not affect cleavage rates compared to controls (-/-); however, if both were 
added during IVM and IVC (R+C/R+C), cleavage rates dropped by 10%, which was 
significantly different from controls.  Interestingly, this treatment combination 
(R+C/R+C) demonstrated the highest blastocyst/putative zygote rate (22.7%), and when 
measured as blastocyst/cleaved rate it was significantly higher than the controls (38% vs 
21%; p<.02).  These results suggest that a combination of retinol and cysteamine during 
IVMC may be detrimental for cleavage, but of those embryos that cleave, more are likely 
to continue development if supplemented with retinol and cysteamine during the first 
three days of culture.  This suggests that retinol and cysteamine are impacting oocyte 
developmental competence, perhaps by decreasing intracellular free radical content.  
Superoxide dismutase (SOD) treatment during IVM of bovine embryos did not increase 
cleavage nor blastocyst/putative zygote rates, but it did improve blastocyst/cleaved rates 
(Luvoni et al., 1996); therefore, it was hypothesized that SOD improved the quality of the 
maturing oocytes.  Van Soom and colleagues observed detrimental effects after adding 
cysteine to culture medium (mSOF) (Van Soom et al., 2002).  They reasoned that mSOF 
contains pyruvate and citrate, two factors that serve as a protectant against ROS; 
therefore, the protective effects of cysteine were diminished.  We did not employ a 
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treatment combination of cysteamine during IVM and retinol during IVC, which may 
have clarified the effects of these compounds. 
Retinol can bind to the cysteine-rich (Zn-finger) regulatory domains of protein 
kinase C (PKC) and cRaf, facilitating the redox activation of these molecules (Hoyos et 
al., 2000).  Therefore, if retinol increases the sensitivity of redox activation, then perhaps 
in our study, addition of retinol and cysteamine decreased free radical production too 
much, and altered the redox state of the embryo.  The intracellular REDOX (reduction-
oxidation) state describes complex interactions of the relative concentrations of various 
oxidized and reduced molecules (Harvey et al., 2002).  Extreme fluctuations in the 
REDOX state of a cell can alter the response of a number of genes and/or transcription 
factors, as well as transport systems such as the cystine transport system which influences 
intracellular glutathione levels (Dröge, 2002).  ROS also serve as critical intracellular 
signaling molecules in signal transduction pathways (Finkel and Sullivan, 2000; 
Thannickal and Fanburg, 2000), and influence gene expression (Palmer and Paulson, 
1997); therefore, slight disruptions may be detrimental to preimplantation embryonic 
development.  This may partially explain negative effects on cleavage by the R+C/R+C 
treatment when applied on Day 1.  ROS may be critical players in signaling pathways, 
which are involved in the embryonic gene transition (Latham and Schultz, 2001), and 
R+C/R+C may alter levels of ROS to the extent that proper cleavage cannot occur.   
On the other hand, the negative combinatorial effects of retinol and cysteamine on 
embryo cleavage may impact mechanisms in addition to protection from oxidative stress.  
Retinoids have been shown to modulate growth factor expression as well as other genes 
important to preimplantation development.  Several reports have described the role of 
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peptide growth factors during embryonic development (review Teruel et al., 2000); 
however, investigators are still unsure of their specific function(s), especially during in 
vitro culture (Kane et al., 1997; Teruel et al., 2000).  Midkine, a member of the heparin-
binding growth/differentiation family is induced by retinoic acid, and it has been found to 
improve bovine oocyte and embryo developmental competence (Ikeda et al., 2000; Ikeda 
et al., 2000).  In addition, retinoic acid was found to regulate epidermal growth factor 
receptor expression (EGFR), (Roulier et al., 1994) and transforming growth factor (TGF-
ß), insulin-like growth factor binding protein (IGFBP3) expression (Han et al., 1997), and 
follicle stimulating hormone receptor (FSHR) expression in granulosa cells (Minegishi et 
al., 2000). 
Retinoids are important regulators of vertebrate cellular development, and 
research has shown its beneficial effects on early embryonic development in vivo 
(Elmarimi et al., 1990; Shaw et al., 1995; Besenfelder et al., 1996; Eberhardt et al., 
1999b), and during in vitro embryo culture (Duque et al., 2002; Livingston et al., 2002).  
In addition, the advantageous effects of maintaining adequate glutathione levels during 
IVM and IVC have been discovered.  In the present study retinol treatment during IVM 
did not appear to increase or decrease glutathione levels of in vitro matured bovine 
oocytes, despite the supporting evidence that retinoids modulated glutathione levels in 
other cell lines (Texeira et al., 1996; Ahlemeyer and Krieglstein, 2000).  However, after 
analyzing our results it would be interesting to examine the glutathione content of the 
resulting blastocysts from retinol and cysteamine treatments. 
Different combinations of retinol and cysteamine were employed in an attempt to 
improve early embryonic development of in vitro produced bovine embryos.  The 
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combination of retinol and cysteamine during IVM and IVC was beneficial as assessed 
by the blastocyst rate; however, the interpretation of this result must be guarded because 
this same treatment appeared harmful to early cleavage stage embryos.  Nevertheless, 
addition of antioxidants to embryo culture medium seems to warrant further 
consideration and evaluation. 
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CHAPTER 5 
 
 
Glutathione Levels of In Vivo Sheep Oocytes and the 
Expression of Manganese Superoxide Dismutase, Cu-Zn 
Superoxide Dismutase, Glutathione Synthetase, and 
Glutathione Transferase-pi 
 
ABSTRACT  
Retinoids play important roles in many diverse biological functions such as cell 
growth, morphogenesis, differentiation, and reproduction.  Previous studies demonstrated 
that retinol administration to ewes, followed by natural service, resulted in embryos with 
improved competence to develop in vitro.  Glutathione is an important non-protein, 
sulphydryl compound found in oocytes and embryos, which acts to decrease oxidative 
stress.  The purpose of the present study was to evaluate the effects of retinol 
administration to ewes on the glutathione content and expression of glutathione-related 
and antioxidant enzymes in mature ovine oocytes.  Briefly, ewes were administered 
retinol or vehicle during superovulation, and after 60 hours the oviducts removed and 
mature oocytes collected.  Glutathione content did not differ significantly between 
oocytes collected from retinol-treated ewes (6.78 ± 3.81 pmol/oocyte) and oocytes from 
control ewes (6.38 ± 1.58 pmol/oocyte).  Transcripts encoding for manganese superoxide 
dismutase (Mn-SOD), copper zinc superoxide dismutase (Cu-Zn SOD), glutathione 
synthetase (GS), and glutathione transferase pi (GSTp) were detected in single ovine 
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oocytes; however, semi-quantitative RT-PCR analysis did not reveal any significant 
differences between oocytes from retinol-treated ewes and those from control ewes. 
 
INTRODUCTION 
Production of reactive oxygen species (ROS) is the natural result of normal, 
physiological cellular processes (review Dröge, 2002).  However, if left unchecked, ROS 
may adversely affect preimplantation embryonic development, especially during in vitro 
culture.  Deleterious effects of ROS include protein, lipid, and nucleic acid damage, 
mitochondrial alterations, cell cycle block, ATP depletion, and excessive apoptosis 
(Salas-Vidal et al., 1998; Guérin et al., 2001).  During in vivo embryonic development, 
enzymatic as well as non-enzymatic antioxidants are present in follicular fluid 
(Schweigert and Zucker, 1988; Carolan et al., 1996; Bisseling et al., 1997; Cassano et al., 
1999), and in reproductive tract secretions to help control the propagation of free radical 
reactions (Gardiner et al., 1998; El Mouatassim et al., 2000); thus, keeping a tight 
regulation on the redox state of the embryo.   
Retinoids play important roles in vision, metabolism, reproduction, bone 
formation, and pattern development during embryogenesis (Gudas et al., 1994; Napoli, 
1996; Wolf, 1996).  Ultimately, the metabolites of vitamin A (retinol), all-trans-retinoic 
acid and 9-cis-retinoic acid, together with their receptors (RARs and RXRs), regulate 
retinoid action at the level of gene expression (Wendling et al., 1999; Konta et al., 2001;  
review Ross et al., 2001).  Vitamin A deficiencies in animals (Moore, 1957; McCollum, 
1964; Ross et al., 2000; Takahashi et al., 2000; Guérin et al., 2001), as well as 
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supplementation with retinol, have clearly defined the importance of this vitamin during 
early embryonic and fetal development (Wellik and DeLuca, 1995; Besenfelder et al., 
1996; Eberhardt et al., 1999b; Whaley et al., 2000).   
Glutathione (GSH), the major non-protein sulphydryl compound found in 
mammalian cells, cycles from a reduced form (GSH) to an oxidized form (GSSG) 
(Deplancke and Gaskins, 2002).  One of the primary responsibilities of glutathione is 
strong basal reactive oxygen species (ROS) scavenging activity (Dröge, 2002), and 
several reports highlight the necessity of maintaining adequate glutathione levels in both 
oocytes and early embryos (Luvoni et al., 1996; Furnus et al., 1998; Knappen et al., 1999; 
de Matos and Furnus, 2000; Shi et al., 2000; Brad et al., 2003).   
Intracellular glutathione synthesis begins with the transulfuration of homocysteine 
to cysteine, the major precursor for GSH synthesis (Deplancke and Gaskins, 2002).  
Next, gamma-glutamyl cysteine synthetase (γ-GCS) combines L-glutamate and cysteine, 
followed by catalysis of glutamate-cysteine and glycine by glutathione synthetase (GS).  
Other important glutathione-related enzymes include glutathione peroxidase, which 
converts GSH to the oxidized form (GSSG) (Arai et al., 1999), glutathione reductase, 
which can reverse this reaction (Anderson, 1985), and glutathione S-transferase-pi 
(GSTp), which catalyzes the conjugation of GSH with deleterious compounds in order to 
protect the cell (Bernardini et al., 1999).   
Many oxidative stress-related enzymes, including those that regulate glutathione 
levels, are found in the reproductive tract, its secretions.  In addition, their transcripts 
and/or proteins have been localized in the oocyte and early embryo (review El 
Mouatassim et al., 1999; Knappen et al., 1999; El Mouatassim et al., 2000).  For 
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example, different levels of expression of GSH, GSSG, cysteine, and Mn-SOD were 
found in different tissues in rabbit and rat embryos (Hansen et al., 2001).  MII stage in 
vivo produced mouse and human oocytes expressed the following mRNA transcripts:  
Cu-Zn SOD, MnSOD, GPx, and GCS (El Mouatassim et al., 1999).  GSTp has been 
localized in human ovarian follicular fluid, and this particular isoform is also important in 
placental function (review Knappen et al., 1999).   
Litter-bearing animals receiving either β-carotene or retinol during superovulation 
displayed an increase in the number of live births (Besenfelder et al., 1993; Coffey and 
Britt, 1993), and an increase in ovulation rate as well as increased recovery of embryos 
(Elmarimi et al., 1990).  Data collected in our lab demonstrated that 1-4 cell and morula 
stage embryos, collected from the oviduct and uterus, respectively, of all-trans-retinol 
treated, superovulated ewes exhibited improved capacity to develop to the blastocyst and 
hatched blastocyst stage during in vitro culture (IVC).  In addition, these experiments 
revealed that most embryos from ewes not treated with retinol (60%) did not progress 
beyond the eight-cell stage in vitro (Eberhardt et al., 1999b).   
Under certain conditions vitamin A, and carotenoids participate in a biological 
antioxidant network, and have been implicated as important regulators of redox signaling 
pathways (Imam et al., 2001).  Specifically, carotenoids quench singlet oxygen molecules 
as well as interact with other antioxidant compounds (Olson, 1993).  Furthermore, 
retinoid addition to cultured neurons prevented glutathione depletion after staurosporine 
treatment (Ahlemeyer and Krieglstein, 2000), and retinoids were also found to decrease 
ROS content and increase SOD levels (Ahlemeyer et al., 2001).  In chondrocyte culture, 
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retinoids increased the activity of glutathione reductase, catalase, and SOD (Texeira et 
al., 1996).   
Based on prior data, which demonstrated in vivo retinol administration improved 
ovine embryonic development (Eberhardt et al., 1999b), and in vitro results, which 
showed that retinol supplementation improved bovine embryonic development 
(Livingston et al., 2002), we speculated that retinol was impacting the follicular 
environment of the developing oocyte.  We hypothesized that retinol may increase the 
glutathione content, and upregulate levels of particular antioxidant enzymes in the in vivo 
matured ovine oocyte; thus, improving future embryonic development.  In vivo matured 
sheep oocytes were collected from oviducts, and the glutathione content measured.  In 
addition, semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) 
was performed on in vivo matured, single ovine oocytes to evaluate the effects of retinol 
on the expression of manganese superoxide dismutase (Mn-SOD), copper-zinc SOD 
(Cu/Zn SOD), glutathione synthetase (GS), and glutathione transferase pi (GSTp) 
transcripts. 
 
 
MATERIALS AND METHODS 
Materials 
All chemicals were purchased from Sigma Chemical Company, St. Louis, MO 
unless otherwise noted.  Mature cross-bred ewes were provided by the University of 
Tennessee, Knoxville Experiment Station.  All animals were maintained on high-quality 
hay fed ad libitum, with free-choice access to a sheep and goat mineral premix that 
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contained 1 million IU of vitamin A per pound.  Progestin-impregnated vaginal implants 
(CIDR-G) were purchased from InterAg, Hamilton, New Zealand.  Follicle stimulating 
hormone (FSH) was purchased from Sioux Biochemical, Sioux Center, IA.  Dulbecco’s 
phosphate buffered saline without Ca++ or Mg++ (DPBS) was purchased from Gibco BRL 
(Grand Island, NY).  Fetal bovine serum (FBS) used in oocyte collection medium was 
purchased from BioWhittaker, Baltimore, MD.  Reverse-transcriptase polymerase chain 
reaction (RT-PCR) kits were purchased from Qiagen, Valencia, CA.  Recombinant 
Rnasin ribonuclease inhibitor (RNase) and electrophoresis standards were purchased 
from Promega, Madison, WI.  Oligonucleotide primer pairs were purchased from Oligos 
Etc., Wilsonville, OR.   
 
Ovine Oocyte Collection  
Mature cross-bred ewes were synchronized with CIDR-G implants for fourteen 
days.  FSH was administered in decreasing doses, twice daily for three days (5 IU, 4 IU, 
3 IU).  On the first and last morning of FSH injections each ewe was also administered 
500,000 IU of all-trans retinol dissolved in corn oil.  Control ewes received only vehicle 
(corn oil).  The implant was changed after 9 days, the second implant was removed on the 
last FSH injection, and surgery was performed approximately 60 hours after implant 
removal.  After the number of corpora lutea were recorded, each oviduct was removed 
and gently flushed with DPBS containing 1% FBS to collect the oocytes.  Oocytes were 
washed three times in DPBS, 1% FBS.  Any remaining cumulus cells were manually 
denuded with a narrow-bore glass pipette.   
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Experiment 1:  GSH Assay 
The GSH assay described is a modification based on the recycling assay of the 
enzyme 5,5-dithiobis-(2-nitrobenzoic acid)-glutathione reductase (DTNB-GSSG), 
described by Tietze (Tietze, 1969) and Calvin (Calvin et al., 1986).  The method 
explained here is most similar to that of Anderson (Anderson, 1985).  The following 
chemicals were purchased from Sigma Chemical Co. (St. Louis, MO):  5,5-dithiobis-(2-
nitrobenzoic acid - DTNB), phosphoric acid (H3PO4), sodium phosphate hydrated 
(NaH2PO4H2O), sodium phosphate (Na2HPO4), ethylenediaminetetraacetic acid (EDTA), 
reduced glutathione, and β-Nicotinamide adenine dinucleotide phosphate reduced 
tetrasodium salt (NADPH), and glutathione reductase. 
After collection, the oocytes were washed three times in stock buffer (0.2 M 
sodium phosphate-0.001 M sodium EDTA, pH 7.2), and transferred to a microcentrifuge 
tube in 5µl.  Phosphoric acid (1.25M, 5µl) was added to achieve a final concentration of 
0.625 M H3PO4.  The oocytes were immediately frozen (-20°C).   
Samples were thawed, centrifuged, and microscopically evaluated to ensure 
complete lysis of the oocytes.  To each sample, 700µl of the NADPH solution (1mL of 
stock buffer added to 1mg bottle of NADPH), 100µl of 6mM DTNB, 180µl of distilled 
water, and 10µl of glutathione reductase (266U/ml) were quickly added to a cuvette, 
placed in a Beckman single-beam DU-640 (Irvine, CA) spectrophotometer, and the 
increase in absorbance (412nm) was measured every 30 seconds for 2 minutes.  Each 
blank included 5µl of water and 5µl of phosphoric acid, and did not show detectable 
amounts of GSH-GSSG.  Four glutathione (GSH) standards were made fresh on the day 
of the assay (1nmol, 0.5nmol, 0.25nmol, and 0.05nmol), in order to calculate the total 
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GSH content of oocytes based on a standard curve (Tietze, 1969; Anderson, 1985; Calvin 
et al., 1986).   
 
Experiment 2:  Oocyte mRNA Isolation and RT-PCR Analysis 
Based on a modification by Fiorenza and Mangia (Fiorenza and Mangia, 1998), 
mRNA was obtained from single ovine oocytes.  Briefly, individual oocytes were placed 
on the cap of a diethylpyrocarbonate (DEPC) treated microcentrifuge tube (200µl) 
containing 10 µl of RNase-free water, and the remaining buffer (DPBS with 1% FBS) 
was aspirated from the cap.  The tube was centrifuged for 30 seconds at 8950 g, and 
promptly frozen at -80°C until analysis.  Before analysis, 10U of RNase inhibitor 
(RNaseI) was added to each tube and frozen/thawed two additional times to ensure 
complete lysis of each oocyte.   
 
Detection of Transcripts Encoding Cu/Zn and Mn Superoxide Dismutases, Histone 
(H2a), Glutathione Synthetase, and Glutathione Transferase-Pi 
 
 Following the manufacturer’s (Qiagen) suggestions, each tube received 40µl of a 
mixture containing RT-PCR buffer (1x), dNTP mix (400µM of each dNTP), 0.6µM of 
each primer, enzyme mix (Omniscript and Sensiscript reverse transcriptase, 
HotStartTaq DNA polymerase), and RNaseI (10U).  All tubes, except for the primer 
pair, Mn-SOD, also received an additional chemical called Q-solution, which is a 
proprietary additive used to improve RT-PCR conditions.   
 Primer pairs for Mn-SOD, Cu/Zn-SOD, and Histone H2a were similar to those 
used in other papers with minor modifications (Hallewell et al., 1991; Meyrick and 
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Magnuson, 1994; Lequarré et al., 2001; Robert et al., 2002), respectively.  Glutathione 
synthetase (GS) was based on a mouse GS sequence, glutathione transferase pi (GSTp) 
was based on a bovine sequence (Table 5-1), and both primer pairs were designed 
according to criteria in the software program, Gene Runner, version 3.05 (Hastings 
Research, Inc., Moraga, CA).  Identification of the amplification products was confirmed 
by sequencing (Genetic Analyzer ABI 3100, University of Tennessee Molecular Biology 
Resource Facility, Knoxville, TN).   
RNA was reverse-transcribed for 30 minutes at 50°C, reverse transcriptase was 
inactivated and DNA polymerase activated at 95°C for 15 minutes, followed by 30-40 
cycles of DNA amplification (depending on the primer pair) run according to 
manufacturers suggestions:  DNA was denatured at 94°C for 1 minute, reannealing was 
achieved at 47°-50.5°C, depending on the primer pair, and extension at 72°C for 1 
minute, and a final extension was performed for 7 minutes at 72°C.  The amplification 
products were separated on either a 2% agarose gel (Mn-SOD, Histone, GS, GSTp) or a 
4% low-melting agarose gel (Cu/Zn SOD, Histone), and visualized with ethidium 
bromide.  Under these conditions each transcript was detected from a single oocyte.  The 
software used to analyze each band was Quantity One  (Bio-Rad Laboratories, 
Hercules, CA).  The abundance of each transcript was determined by dividing the 
intensity of the band of interest by the intensity of the standard (histone) (Knijn et al., 
2002). 
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Table 5-1.  Antioxidant-related transcripts detected in singe sheep oocytes. 
 
 
Gene 
 
 
Primer sequence Reference Product 
size (bp) 
Number of 
Cycles 
Annealing 
Temperature (°C) 
Histone H2a 
Sense 
Antisense 
 
5′ GTCGTGGCAAGCAAGGAG 3′ 
5′ GATCTCGGCCGTTAGGTACTC 3′ 
Mouse (Robert et 
al., 2002) 
 
 
182 
Depended on 
primer pair 
 
47.0 - 50.5°C 
Mn-SOD 
Sense 
Antisense 
 
5′ CACCACAGCAAGCACCA 3′ 
5′ TCCCACACGTCAATCCC 3′ 
Bovine 
(Meyrick & 
Magnuson, 1994) 
 
409 
 
30 
 
47.0°C 
Cu/Zn-SOD 
Sense 
Antisense 
 
5′ GAAGAGAGGCATGTTGGAG 3′ 
5′ CCAATTACACCACGAGCC 3′ 
Bovine 
(Hallewell et al., 
1991) 
 
226 
 
30 
 
47.0°C 
GS 
Sense 
Antisense 
 
5′ GGTGCTACTGATTGCTCAAG 3′ 
5′ GCTCAGGTTCAATCTTCTCC 3′ 
GenBank Accession 
number 
NM_008180 
 
598 
 
40 
 
 
50.0°C 
GSTp 
Sense 
Antisense 
 
5′ CCTCCCTACACCATCGTC 3′ 
5′ TCCTCTACACCGTCATTCAC 3′ 
GenBank Accession 
number 
NM_177516 
 
292 
 
35 
 
50.5C 
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Data Analysis 
 Data from Experiment 1 and 2 both were analyzed using chi-square analysis to 
detect differences between oocytes from retinol treated ewes and control ewes. 
 
RESULTS  
 The glutathione content of in vivo matured sheep oocytes did not significantly 
differ between oocytes collected from ewes treated with retinol (6.78 ± 3.81 pmol/oocyte) 
versus ewes not exposed to retinol (6.38 ± 1.58)  (Figure 5-1).  Together, over 260 
oocytes were collected and assayed for glutathione. 
The transcripts of Histone H2a, Mn-SOD, Cu-Zn SOD, GS, and GSTp were 
detected in in vivo mature ovine oocytes.  As depicted in Table 5-1 all PCR products 
showed the expected size, and their identity was confirmed by sequencing.  The sequence 
of each product was confirmed by a BLAST search in GenBank.  The GS transcript 
expressed 89% homology with previously published sequences of GS, GSTp (98%), Mn-
SOD (98%), Cu-Zn SOD (98%), and Histone H2a (87%). 
Examining the relative abundance of each transcript did not reveal differences 
between oocytes from retinol-treated ewes versus controls.  The transcripts encoding for 
Mn-SOD (Figure 5-2) were detected in all oocytes tested (24/24), for Cu-Zn SOD  94% 
(17/18) of the oocytes expressed the transcript (Figure 5-3), GS transcripts (Figure 5-4) 
were found in 96% (27/28) of the oocytes analyzed, and 100% of the oocytes (16/16) 
expressed GSTp (Figure 5-5).   Histone (Figures 5-2 – 5-5) was used as an internal 
control because it had previously been detected at all stages of bovine embryo  
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Figure 5-1.  Glutathione content of in vivo matured sheep oocytes. 
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                Figure 5-2.  Expression of the Mn-SOD and Histone H2A transcripts in single,   
                mature sheep oocytes.  Lanes 1 & 17 (M): Marker.  Lanes 2-8: Oocytes from  
                control ewes.  Lane 9:  Blank.  Lanes 10-16:  Oocytes from retinol-treated  
    ewes. 
 
 
 
Figure 5-3.  Expression of the Cu-Zn SOD and Histone H2A transcripts in single, 
mature sheep oocytes.  Lanes 1 (M): Marker.  Lanes 2-4: Oocytes from control 
ewes.  Lane 5:  Blank.  Lanes 6-8:  Oocytes from retinol-treated ewes. 
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Figure 5-4.  Expression of the GS and Histone H2A transcripts in single, mature 
sheep oocytes.  Lanes 1 (M): Marker.  Lanes 2-4: Oocytes from control ewes.  
Lane 5:  Blank.  Lanes 6-8:  Oocytes from retinol-treated ewes. 
 
 
 
Figure 5-5.  Expression of the GSTp and Histone H2A transcripts in single, 
mature sheep oocytes.  Lanes 1 (M): Marker.  Lanes 2-4: Oocytes from control 
ewes.  Lane 5:  Blank.  Lanes 6-8:  Oocytes from retinol-treated ewes. 
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development to the blastocyst stage in the same quantity (Robert et al., 2002).  Our 
results showed that this transcript did not appear to differ between treatments; therefore, 
it was an appropriate internal control to use in this study. 
 
DISCUSSION 
Retinol administration to ewes during gonadotropin-induced follicular maturation 
resulted in an increased development to the blastocyst stage in vitro (Eberhardt et al., 
1999b).  In addition, retinol supplementation to bovine oocytes during in vitro maturation 
tended to improve embryonic development (Livingston et al., 2002); therefore, maturing 
oocytes within the follicular environment were considered likely targets of retinoid 
action.  Based on previous reports in other cell lines that retinoids modulated glutathione 
levels (Ahlemeyer and Krieglstein, 2000; Ahlemeyer et al., 2001), and other antioxidants 
(Texeira et al., 1996), we hypothesized that retinol may increase the glutathione levels in 
oocytes, and/or increase levels of antioxidant enzymes that ultimately enhance embryonic 
development. 
The glutathione content of in vivo matured ovine oocytes (Figure 5-1) from retinol-
treated ewes (6.78 ± 3.81 pmol/oocyte) did not differ significantly from control oocytes 
(6.38 ± 1.58 pmol/oocyte).  To our knowledge, this is the first time glutathione content 
has been measured in superovulated, in vivo derived ovine oocytes.  Our values are 
similar to those reported after in vitro maturation of ovine oocytes (de Matos et al., 2002).  
In contrast, Brad and colleagues observed that in vivo matured porcine oocytes had an 
increased concentration of glutathione compared to their in vitro matured counterparts 
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(Brad et al., 2003).  This apparent contradiction in GSH content of in vivo versus in vitro 
matured oocytes between sheep and swine could result from species differences, 
methodology employed, or treatment effects.  Superovulation may also have affected the 
GSH content because Foote and Ellington detected differences between normal ovulated 
bovine oocytes versus superovulated ones (Foote and Ellington, 1988). 
 In experiment 2, mature ovine oocytes were collected from the oviducts of 
superovulated ewes to evaluate the effects of retinol on Mn-SOD, Cu-Zn SOD, GS, and 
GSTp expression.  RT-PCR analysis on single oocytes detected transcripts for each gene 
(Figures 5-2 – 5-5).  In fact, using this procedure each transcript was detected in over 
95% of the oocytes analyzed, demonstrating the efficacy of this technique. 
 Mn-SOD is present in the mitochondria and Cu-Zn SOD is located in the 
cytoplasm (McCord and Fridovich, 1969; Weisiger and Fridovich, 1973).  Both are 
responsible for converting the superoxide anion (O2-) to H2O2, which is then removed by 
catalase and/or glutathione peroxidase (Guérin et al., 2001).  Studies have demonstrated 
benefits of Mn-SOD addition to simple culture medium (Luvoni et al., 1996; Orsi and 
Leese, 2001).  In the current study, we detected Mn-SOD transcripts in 24/24 oocytes, 
and Cu-Zn SOD was found in 17/18 oocytes analyzed.  Transcripts for Mn-SOD and Cu-
Zn SOD have been detected in in vitro matured (IVM) bovine oocytes (Lequarré et al., 
2001), and in human and mouse in vivo matured oocytes (El Mouatassim et al., 1999).  
The presence of these transcripts in bovine, ovine, mouse, and human suggests these 
defense mechanisms are conserved, and important for early embryonic development.  
However, Mn-SOD was detected in only 60% of in vitro matured bovine oocytes 
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(Lequarré et al., 2001), which may indicate a significant difference between in vivo and 
in vitro derived oocytes.   
 Few studies have studied the transcriptional expression or regulation of 
glutathione synthetase (GS), particularly during embryonic development.  This enzyme 
catalyzes the formation of γ-glutamylcysteine and L-glycine, the final step in glutathione 
synthesis.  In this study, the transcript for GS was detected in 27/28 oocytes analyzed.  
Other studies have confirmed the presence of the rate-limiting enzyme, γ-
glutamylcysteine synthetase, in mature human, mouse, and bovine oocytes (Harvey et al., 
1995; El Mouatassim et al., 1999).   
Glutathione transferase pi (GSTp) is one of nine gene families that exist in the 
GST superfamily (Ketterer, 2001).  The GSTs are well known xenobiotic metabolic 
enzymes, playing a role in the detoxification process by catalyzing the conjugation of 
glutathione to toxic or foreign compounds (Knappen et al., 1999).  GSTp has also been 
shown to protect cells from oxidative stress-induced cell death (Yin et al., 2001).   High 
levels of GSTp1 expression have been found in fetal tissues (Knappen et al., 1999), and 
correlated with physiological cellular proliferation (Ketterer, 2001).  GSTp and GST-
alpha were both detected in the follicular fluid of women undergoing infertility 
treatments (Bisseling et al., 1997).  Furthermore, GSTp was found in the greatest 
amounts in early human embryonic and fetal tissues (8 and 13 weeks gestational age) 
(Raijmakers et al., 2001).  Ours is the first study to demonstrate that at least one gene 
family of GSTs, GSTp, is expressed in mature ovine oocytes; thus, suggesting the oocyte 
has the capacity for detoxifying toxic compounds, and managing oxidative stress.  An 
allelic variant of GSTp was found to contain a retinoic acid response element (RARE), 
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suggesting retinoic acid may play a role in the molecular regulation of GSTp (Lo and Ali-
Osman, 1997). 
Retinol administration during superovulation to ewes did not appear to affect the 
mRNA expression of transcripts for the antioxidant enzymes studied.  However, it is 
possible that the protein levels of one or more of these enzymes are modified in a way 
that improves future embryonic development.  In fact, in one report RA supplementation 
during cell culture did not alter SOD transcript levels, but it upregulated SOD protein 
levels (Ahlemeyer et al., 2001).  
Alternatively, retinol may not be acting directly on the oocyte, but rather 
indirectly affecting other reproductive tract cells, or the granulosa and/or theca cells in a 
way that ultimately benefits the oocyte.  In addition, retinoids may directly or indirectly 
modulate antioxidant-inducible genes (review Primiano et al., 1997).  Antioxidant-
inducible genes include GSTs, cytochrome P450s, aldehyde dehydrogenases, glutathione-
related enzymes, and many others (review Primiano et al., 1997).  Although the positive 
effects previously detected by retinol supplementation during in vitro culture (Livingston 
et al., 2002) may be explained by an upregulation of antioxidant-induced enzymes, the 
question remains:  does the same hold true for an in vivo derived oocyte or embryo that is 
already surrounded by protective mechanisms present in the follicular and oviductal 
fluid?  If not, then the mechanism of action in vivo may be different than during in vitro 
culture.   
Retinoids are known to impact a variety of genes and/or transcription factors such 
as midkine, a member of the heparin-binding growth/differentiation family, which is 
induced by retinoic acid, and has been found to improve bovine oocyte and embryo 
 105
developmental competence (Ikeda et al., 2000; Ikeda et al., 2000).  In addition, retinoic 
acid was found to regulate epidermal growth factor receptor expression (EGFR), (Roulier 
et al., 1994) and transforming growth factor (TGF-ß), insulin-like growth factor binding 
protein (IGFBP3) expression (Han et al., 1997), and follicle stimulating hormone receptor 
(FSHR) expression in granulosa cells (Minegishi et al., 2000).  Retinoic acid also 
modulated the expression of cell cycle proteins such as MAPK (Alsayed et al., 2001).  
Perhaps, retinol is impacting the oocyte in a way to synchronize its cell cycle, in order to 
endure sub-optimal in vitro culture conditions. 
For the first time, glutathione content was measured in in vivo derived, mature 
ovine oocytes, and the values correspond to other published values (de Matos et al., 
2002).  In addition, transcripts encoding for Mn-SOD, Cu-Zn SOD, GS, and GSTp were 
detected in over 95% oocytes collected; however, differences between oocytes collected 
from retinol-treated ewes and control oocytes were not detected based on a semi-
quantitative RT-PCR analysis.  The presence of these transcripts suggests that an 
endogenous pool of antioxidant enzymes exist in the oocyte, stored as mRNA, 
presumably to assist future development. 
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CHAPTER 6  
Summary 
 
The effects of retinoids on embryogenesis and fetal development have been 
studied extensively over the past 20-30 years (review Hofmann and Eichele, 1994; Båvik 
et al., 1996; Ghyselinck et al., 1997; Neiderreither et al., 1999; review Ross et al., 2000).  
Retinoids impact embryogenesis, providing critical positional information by influencing 
Hox genes, which control anterior/posterior body patterning (review Hofmann and 
Eichele, 1994; review Marshall et al., 1996).  In addition, retinoic acid regulates WNT 
genes (Katoh, 2002), which serve important roles during neural differentiation, and have 
been characterized in the ovary (Ricken et al., 2002).  Oct-4, a member of the POU 
transcription factor family is correlated with an undifferentiated phenotype in embryos 
(Ovitt and Scholer, 1998; Kirchhof et al., 2000).  Evidence exists that this protein may be 
modulated by retinoic acid (Ovitt and Scholer, 1998).  
Studies have confirmed the necessity of maintaining a homeostatic balance of 
retinoid metabolizing enzymes, binding proteins and retinoid receptors in order to avoid a 
vitamin A deficient or excessive state (Mangelsdorf et al., 1994; Ghyselinck et al., 1999;  
review Noy, 2000).  Our laboratory and others have presented evidence that retinol 
supplementation during gonadotropin-induced follicular maturation improves embryonic 
development and subsequent pregnancies (Elmarimi et al., 1990; Besenfelder et al., 1996; 
Whaley et al., 1997; Eberhardt et al., 1999b; Whaley et al., 2000; Hidalgo et al., 2002; 
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Hidalgo et al., 2003).  Addition of retinoids during in vitro culture also proved beneficial 
for embryonic development to the blastocyst stage (Duque et al., 2002; Livingston et al., 
2002).  Based on this data, we hypothesized that retinol may be exerting its effect on the 
maturing oocyte; therefore, we designed in vivo studies with sheep and in vitro 
experiments with bovine embryos to evaluate the effects of retinol, in an effort to 
understand its mechanism(s) of action.  
The first study measured sheep oocyte metabolism, and evaluated the role of 
retinol on this process.  Using radiolabeled substrates to measure the evolution of 14CO2 
and 3H2O, this was the first time sheep oocyte metabolism had been measured over the 
entire twenty-four hour maturation period.  Results showed that oxidative metabolism 
measured by glutamine showed no significant differences over all time periods.  Pyruvate 
oxidation was highest early in maturation and then decreased.  Glutamine oxidation 
appeared to be most active early and then declined.  Glycolysis was highest at the middle 
time period.  These results suggest that ovine oocytes use both glycolysis and oxidative 
pathways throughout IVM; thus, providing insight into the nutritional and energy 
requirements of the maturing ovine oocyte.  Perhaps due to a lack of sensitivity of our 
assay, we did not detect significant differences in metabolism between oocytes from 
retinol-treated ewes and those from control ewes. 
Our next study was performed in order to determine the in vitro effects of retinol 
on bovine preimplantation development.  Varying concentrations of retinol were added 
either during IVM or IVC.  Our results demonstrated that 5µM retinol supplementation 
during IVM tended to improve embryonic development measured by the rate of 
blastocyst development.  Interestingly, this concentration proved even more beneficial if 
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the control blastocyst rate was below 20%.  Furthermore, 10µM retinol appeared 
detrimental during IVC but not during IVM.  We postulated this was due to a protective 
effect of cumulus cells.   
Based on previous in vivo and in vitro retinoid experiments, and data from studies 
demonstrating the importance of glutathione (de Matos and Furnus, 2000; de Matos et al., 
2002), we hypothesized that retinol addition to the medium may increase oocyte 
glutathione levels.  In addition, we investigated the combinatorial effects of retinol and 
cysteamine on in vitro bovine embryonic development.  We did not observe an increase 
in glutathione levels in bovine oocytes treated with retinol, perhaps due to a decreased 
uptake of cysteine from the culture medium.  However, in the presence of cysteamine 
bovine oocytes exhibited an increase in glutathione content.  Retinol and cysteamine 
treatment during IVM and IVC increased bovine blastocyst development, which may 
indicate that retinol increases the utilization or uptake of cysteine from the medium. 
Next, we evaluated the role of exogenous retinol supplementation to 
superovulated ewes on the glutathione content of mature oocytes collected from the 
oviducts.  Our results did not reveal differences in glutathione content of oocytes from 
retinol-treated versus those from vehicle-treated ewes.  Antioxidant transcripts encoding 
for Mn-SOD, Cu-Zn SOD, GS, and GSTp, were detected in in vivo matured ovine 
oocytes. However, retinol did not appear to impact the expression levels of these 
transcripts. 
Overall, retinol addition during IVM appeared beneficial for embryonic 
development, but its effects during IVC were concentration dependent.  Although 
glutathione levels were not altered significantly during IVM, the effects of retinol may 
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become more apparent later in development, perhaps during the blastocyst stage when 
glutathione levels increase.  Adding both retinol and cysteamine during IVM and IVC 
proved beneficial.  The in vivo metabolism study did not detect any significant 
differences between oocytes from retinol-treated versus control ewes, nor did our in vivo 
data confirm that retinol was altering glutathione levels in mature ovine oocytes. 
In vivo conditions differ from culture conditions, but an embryo must still respond 
appropriately to the varying environment of the oviduct and uterus.  Retinol may 
modulate growth factors, hormones, or other substances that are necessary for embryonic 
development.  Additionally, the positive effect of retinol administration may have a more 
indirect effect on the oocyte or follicle, impacting the follicular environment and/or the 
oviductal secretions.  A study conducted in our laboratory, demonstrating that more 
pregnancies and subsequent births resulted from frozen embryos collected from retinol-
treated ewes (unpublished) suggests that retinol is positively influencing early 
preimplantation development; however, its mechanism of action is still unclear. 
Organisms living in an aerobic environment are exposed to reactive oxygen 
species (ROS) that are produced by normal, cellular processes such as aerobic 
metabolism (Martindale and Holbrook, 2002).  In vitro culture exposes cells to further 
ROS by exogenous stimuli such as light and experimental manipulation (Guérin et al., 
2001).  Depending on their concentration, ROS serve important regulatory functions 
(Thannickal and Fanburg, 2000; Dröge, 2002; Martindale and Holbrook, 2002), by 
altering the intracellular redox state or creating oxidative modifications in proteins 
(Thannickal and Fanburg, 2000).  The redox state of a cell is important in terms of how it 
respond to signals, i.e., apoptosis, proliferation, or differentiation.  Some studies have 
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suggested that cells contain a redox sensor, an unidentified protein or complex that senses 
the redox state of the cell and responds appropriately (Gutteridge, 1995; Primiano et al., 
1997) (Figure 6-1). 
Retinoids can act in a variety of ways that ultimately impacts cellular physiology 
such as altering levels of kinases, contractile elements, and gene expression (Gudas et al., 
1994).  Retinol may be affecting embryonic development in one of three ways:  
modulating apoptosis, acting as an antioxidant, and/or regulating growth factor 
expression.   
Several reports have provided clear evidence that retinoids, particularly retinoic 
acid (RA), suppressed apoptosis in a number of cell lines (Moreno-Manzano et al., 1999; 
Ahlemeyer and Krieglstein, 2000; Ahlemeyer et al., 2001; Antipatis et al., 2002).  
Furthermore, many studies, especially those in vitro demonstrated that excessive 
apoptosis during embryonic development is detrimental (Hardy, 1999; Morita and Tilly, 
1999; Matwee et al., 2000; Van Soom et al., 2002).  The biochemical pathway that 
mediates the retinoid suppression of apoptosis most likely involves the stress-activated 
kinase, known as c-jun terminal kinase (JNK).  For example, RA was shown to inhibit 
JNK activation in mesangial cells exposed to H2O2  (Figure 6-1).  Specifically, the study 
found RA decreased c-Jun/c-Fos heterodimerization (Moreno-Manzano et al., 1999), 
which are necessary components of activating protein 1 (AP-1) (Figure 6-2).  AP-1 is 
regarded as a redox-sensitive transcription factor that regulates the expression of several 
genes, including those involved in apoptosis (Palmer and Paulson, 1997).  Moreover, RA 
was found to increase the levels of mitogen-activated protein kinase phosphatase 1  
 111
 
 
 
 
 
Figure 6-1.  The redox pathway and potential mechanisms of action of retinoids in the 
cytoplasm during embryonic development. 
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Figure 6-2.  The redox pathway and potential mechanisms of action of retinoids 
in the nucleus during embryonic development.
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(MKP-1), which inactivates MAPKs such as JNK and p38 MAPK (Xu et al., 2002)  
(Figure 6-2). 
Interestingly, AP-1 can also increase the levels of xenobiotic metabolizing 
enzymes, such as glutathione transferase pi (GSTp), which ultimately influence the levels 
of intracellular glutathione (Figure 6-1).  Under normal cellular conditions GSTp inhibits 
JNK activity (Adler et al., 1999), but in an oxidative stress-induced environment GSTp 
allows JNK to phosphorylate c-Jun, and AP-1 to be expressed.  GSTp was found to 
contain a RARE (Lo and Ali-Osman, 1997), which was induced by RA treatment, 
suggesting another mechanism through which retinol may be acting. 
The intracellular defense program must be intricately regulated to maintain 
homeostasis; therefore, multiple and complementary protection mechanisms are present 
in the oocyte and embryo and its environment (Guérin et al., 2001), including 
antioxidants.  ROS exist in the mitochondria, cytoplasm, and cell membrane.  They can 
be highly reactive such as OH•, and some ROS have different ½ lives; therefore, cells 
need diverse antioxidants to manage different kinds and levels of ROS (Gutteridge, 
1995).  For example, Vitamin E and its metabolites serve as radical chain breakers, 
radical scavengers include Ubiquinol 10, and β-carotene and retinoids provide defense 
against singlet oxygen quenchers. 
The difficulty in assessing whether retinol is acting as an antioxidant either in 
vitro or in vivo is that vitamins, depending on their concentration and the state of the cell, 
can act as prooxidants or antioxidants (Herbert, 1996; Primiano et al., 1997).  In fact, the 
chemistry of retinol, with its pi electrons allows it to exhibit both pro- and antioxidant 
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properties (Hoyos et al., 2000).  One report even states that precautions must be taken 
when adding single antioxidants to the medium as they could have prooxidant effects 
(Guérin et al., 2001).   
Recently, it was observed that retinol binds to the cysteine residues in the catalytic 
sites of the serine/threonine kinases, protein kinase C (PKC) and c-Raf (Hoyos et al., 
2000; Imam et al., 2001); however, only under oxidizing conditions did retinol activate 
and increase the activity of these proteins.  Raf ultimately leads to extracellular regulated 
kinase (ERK) activation and cellular proliferation (Finkel and Sullivan, 2000; Scita et al., 
2000); thus, a possible mechanism by which retinol may be influencing embryonic 
development is through cellular proliferation (Figure 6-1). 
Intracellular levels of glutathione play important roles in determining the redox 
state of the cell.  Retinoids have been shown to inhibit the depletion of glutathione 
(Ahlemeyer and Krieglstein, 2000) and modulate glutathione peroxidase levels (Texeira 
et al., 1996) (Figure 6-1).  One study provided evidence that glutathione depletion caused 
a hyperinduction of the JNK pathway, but if the cells were pretreated with N-
acetylcysteine or glutathione this pathway was inhibited (Wilhelm et al., 1997).  Thus, in 
our system, retinol may be converted to retinoic acid or another derivative that ultimately 
binds to and activates RAR/RXR.  This receptor complex may then bind to antioxidant 
response elements (ARE) of certain antioxidant inducible genes (Primiano et al., 1997), 
which influence JNK and p38 MAPK pathways.   
Retinoids have been shown to modulate growth factor expression as well as other 
genes important to preimplantation development.  Several reports have described the role 
of peptide growth factors during embryonic development (review Teruel et al., 2000); 
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however, investigators are still unsure of their specific function(s), especially during in 
vitro culture (Kane et al., 1997; Teruel et al., 2000).  Midkine, a member of the heparin-
binding growth/differentiation family is induced by retinoic acid, and has been found to 
improve bovine oocyte and embryo developmental competence (Ikeda et al., 2000; Ikeda 
et al., 2000).  In addition, retinoic acid was found to regulate epidermal growth factor 
receptor expression (EGFR), (Roulier et al., 1994), transforming growth factor (TGF-ß), 
insulin-like growth factor binding protein (IGFBP3) expression (Han et al., 1997), and 
follicle stimulating hormone receptor (FSHR) expression in granulosa cells (Minegishi et 
al., 2000). 
Future work to define and clarify retinol’s mechanism of action may include 
working in a completely defined system to evaluate retinol’s affects, because serum and 
bovine serum albumin (BSA) may contain protective compounds (Ahlemeyer and 
Krieglstein, 2000).  Comparing gene expression of the antioxidant transcripts between in 
vivo and in vitro derived oocytes may also provide necessary clues about how retinol is 
influencing early embryonic development.  In fact, LeQuarre and colleagues have 
discovered that in vitro matured bovine oocytes are heterogeneous in their expression of 
certain genes, and this may correlate with developmental capacity (Lequarré et al., 1997).  
DNA microarray may also be very useful in discerning the mechanistic actions of retinol.  
Although in vitro culture induces oxidative stress, future experiments may include 
imposing oxidative stress with H2O2 or other compounds, and evaluating the effects of 
retinol.  Furthermore, using specific mice strains that are null mutants for one or more 
retinoid related enzyme(s) or receptor(s) may also help dissect the mechanistic effects of 
retinol.   
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